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Both observational and perturbational technologies are essential for advancing the understanding of brain
function and dysfunction. But while observational techniques have greatly advanced in the last century, tech-
niques for perturbation that are matched to the speed and heterogeneity of neural systems have lagged
behind. The technology of optogenetics represents a step toward addressing this disparity. Reliable and
targetable single-component tools (which encompass both light sensation and effector function within
a single protein) have enabled versatile new classes of investigation in the study of neural systems. Here
we provide a primer on the application of optogenetics in neuroscience, focusing on the single-component
tools and highlighting important problems, challenges, and technical considerations.Introduction
Optogenetics, as the term has come to be commonly used,
refers to the integration of optics and genetics to achieve gain-
or loss-of-function of well-defined events within specific cells
of living tissue (Deisseroth et al., 2006; Scanziani and Ha¨usser,
2009; Deisseroth 2010, 2011). For example, microbial opsin
genes can be introduced to achieve optical control of defined
action potential patterns in specific targeted neuronal popula-
tions within freely movingmammals or other intact-system prep-
arations. Interdisciplinary by nature, optogenetics requires (1)
engineered control tools that can be readily targeted to specific
cells, (2) technologies for light delivery, and (3) methods for inte-
grating optical control with compatible readouts (such as fluores-
cent organic or genetically encoded activity indicators, electrical
recording, fMRI signals, or quantitative behavioral analysis).
Aspects of the conceptual inspiration for optogenetics can be
traced to the 1970s. In 1979 Francis Crick, taking note of the
complexity of the mammalian brain and the fact that electrodes
cannot readily distinguish different cell types (Crick, 1979), sug-
gested that a major challenge facing neuroscience was the need
toprecisely control activity in one cell typewhile leaving theothers
unaltered. Crick later speculated in lectures that light might be a
relevant control tool, but without a concept for how this could
be done. Yet years earlier (in an initially unrelated line of research),
bacteriorhodopsin had been identified (Oesterhelt and Stoecke-
nius, 1971, 1973) as amicrobial single-component light-activated
ion pump. Further work in thousands of papers over the ensuing
decades led not only to deeper understanding of bacteriorho-
dopsin but also to the discovery of many new members of this
microbial opsin family, which includes membrane-bound ion
pumps and channels such as halorhodopsins (Matsuno-Yagi
and Mukohata, 1977) and channelrhodopsins (Nagel et al.,
2002) that transport various ions across the membrane in
response to light (Matsuno-Yagi and Mukohata, 1977; Lanyi and
Oesterhelt, 1982; Schobert and Lanyi, 1982; Be´ja` et al., 2000;
Nagel et al., 2002, 2003; Ritter et al., 2008; Zhang et al., 2008).It took decades for these two concepts to be brought
together by neuroscientists, although microbial opsin genes
were widely known and had long been understood to give
rise to single-component light-activated regulators of trans-
membrane ion conductance. But there were fundamental
caveats for those who considered such a possibility for optical
neural control over the decades, including the presumption that
photocurrents would be too weak and slow to control neurons
efficiently, the presumption that microbial membrane proteins
in fragile mammalian neurons would be poorly expressed or
toxic, and most importantly the presumption that additional
cofactors such as all-trans retinal (the separate organic light-
absorbing chromophore employed by microbial opsins) would
have to be added to any intact-tissue experimental system.
These preconceptions (strikingly similar to those that slowed
the development of green fluorescent protein) were all reason-
able enough to deter experimental implementation, and efforts
were therefore focused elsewhere. Yet in the summer of 2005 it
was reported that introduction of a single-component microbial
opsin gene into mammalian neurons (without any previously
tested or other component) resulted in reliable sustained
control of millisecond-precision action potentials (Boyden
et al., 2005); many additional papers from work conducted
contemporaneously appeared over the next year (Li et al.,
2005; Nagel et al., 2005; Bi et al., 2006; Ishizuka et al., 2006).
Moreover, while retinoids were already well known to be
present in large quantities in embryonic tissues and in the
retina, it was soon found that mature mammalian brains (Dei-
sseroth et al., 2006; Zhang et al., 2006), and indeed all verte-
brate tissues thus far examined (e.g., Douglass et al., 2008)
contain sufficient all-trans retinal for microbial opsin genes to
define a single-component strategy. By 2010 the major classes
of ion-conducting microbial opsins (including bacteriorho-
dopsin, channelrhodopsin, and halorhodopsin) had all proven
to function as optogenetic control tools in mammalian neurons,
as described below.Neuron 71, July 14, 2011 ª2011 Elsevier Inc. 9
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cells (for example, involving cascades of multiple genes or
combinations of genes and custom organic chemicals (Zemel-
man et al., 2002, 2003; Banghart et al., 2004; Lima and Miesen-
bo¨ck, 2005; Kramer et al., 2005; Volgraf et al., 2006) have been
recently reviewed (Gorostiza and Isacoff, 2008; Miesenbo¨ck,
2009), here we provide a primer focusing on single-component
optogenetics, delineating guiding principles for scientific investi-
gation and summarizing the enabling technologies for neurosci-
ence application. However, most of the techniques developed
for this approach (ranging from genetic targetingmethods, to ad-
dressing experimental confounds, to intact-system light delivery
methods) will be relevant to any biological system or optogenetic
strategy. We do not attempt to review in any form the very large
number of papers and results that have emerged in this field,
nor to address every technique, reagent, and device linked to
optogenetics. Rather, here we highlight limitations, challenges,
and obstacles in the field and outline general principles for
designing, conducting, and reporting optogenetic experiments.
Microbial Opsin Genes
Optogenetics is not simply photoexcitation or photoinhibition
of targeted cells; rather, optogenetics must deliver gain or loss
of function of precise events—just as in genetics, where
single-gene manipulations are the core currency of the field.
This means that in neuroscience, millisecond-scale precision is
essential to true optogenetics, to keep pace with the known
dynamics of the targeted neural events such as action potentials
and synaptic currents. Moreover, this level of precision must
be operative within intact systems including freely moving
mammals. All strategies to achieve optical control, including
those involving microbial opsin genes, initially displayed serious
limitations in meeting this goal. The multicomponent character,
longer-timescale temporal properties, and/or requirement for
high-intensity UV light characteristic of the earlier strategies
(Zemelman et al., 2002; Banghart et al., 2004; Lima and Miesen-
bo¨ck, 2005; Kramer et al., 2005) have limited adoption and appli-
cation to mammalian and other systems, but single-component
microbial opsin gene strategies also initially displayed problems
as well ranging from inadequate control capability (Boyden et al.,
2005; Gunaydin et al., 2010) to toxicity (Gradinaru et al., 2008,
2010; Zhao et al., 2008) to challenges linked to light delivery
in vivo (Aravanis et al., 2007; Adamantidis et al., 2007). A long
process of tool engineering and substantial development of
enabling technologies was required over the next several years.
The key properties of these microbial optogenetic tools relate
to the ecology of their original host organisms, which respond to
the environment using seven-transmembrane proteins encoded
by the type I class of opsin gene (Yizhar et al., 2011b). Type I
opsins are protein products of microbial opsin genes and are
termed rhodopsins when bound to retinal. However, in typical
heterologous expression experiments the precise composition
of retinoid-bound states is uncharacterized. Therefore in the
setting of neuroscience application, the tools are conservatively
referred to as opsins (amore accurate and convenient shorthand
for common use, since only ‘‘opsin’’ correctly applies to the
genes as well as to the protein products). These proteins are
distinguished from their mammalian (type II) counterparts, in10 Neuron 71, July 14, 2011 ª2011 Elsevier Inc.that they are single-component light-sensing systems; the two
operations—light sensing and ion conductance—are carried
out by the same protein.
The first identified, and still by far the best studied, type I
protein is the haloarchaeal proton pump bacteriorhodopsin
(BR; Figure 1A; Oesterhelt and Stoeckenius, 1971, 1973; Racker
and Stoeckenius, 1974). Under low-oxygen conditions, BR is
highly expressed in haloarchaeal membranes and serves as
part of an alternative energy-production system, pumping
protons from the cytoplasm to the extracellular medium to
generate a proton-motive force to drive ATP synthesis (Racker
and Stoeckenius, 1974; Michel and Oesterhelt, 1976). These
light-gated proton pumps have since also been found in a wide
range of marine proteobacteria as well as in other kingdoms of
life, where they employ similar photocycles (Be´ja` et al., 2001;
Va´ro´ et al., 2003) and have been hypothesized to play diverse
roles in cellular physiology (Fuhrman et al., 2008).
A second class of microbial opsin genes encodes halorhodop-
sins (Figure 1A). Halorhodopsin (HR) is a light-activated chloride
pump first discovered in archaebacteria (Matsuno-Yagi and
Mukohata, 1977). The operating principles of halorhodopsin
(HR) are similar to those of BR (Essen, 2002), with the two
main differences being that halorhodopsin pumps chloride ions
and its direction of transport is from the extracellular to the intra-
cellular space. Specific amino acid residues have been shown to
underlie the differences between BR and HR in directionality and
preferred cargo ion (Sasaki et al., 1995). After initial identification
of halorhodopsin, other members of this class soon followed;
for example, Lanyi and colleagues expanded the family by iden-
tifying a halorhodopsin from Natronomonas pharaonis in 1982
(NpHR; Lanyi and Oesterhelt, 1982).
Next, a third class of conductance-regulating microbial opsin
gene (channelrhodopsin or ChR) was identified (Figure 1A).
Nagel and Hegemann demonstrated light-activated ion-flux
properties (Nagel et al., 2002) for a protein encoded by one of
the genomic sequences from the green algae Chlamydomonas
reinhardtii, as Stoeckenius, Oesterhelt, Matsuno-Yagi, and
Mukohata had earlier for the proteins halorhodopsin and
bacteriorhodopsin. Subsequent papers from several groups
described a second and third channelrhodopsin (Nagel et al.,
2003; Zhang et al., 2008), and many more will follow. While
ChR is highly homologous to BR, especially within the trans-
membrane helices that constitute the retinal-binding pocket,
in channelrhodopsins the ion-conducting activity is largely un-
coupled from the photocycle (Feldbauer et al., 2009); an effective
cation channel pore is opened, which implies that ion flux
becomes independent of retinal isomerization and rather
depends on the kinetics of channel closure. In neurons, net
photocurrent due to ChR activation is dominated by cation
flow down the electrochemical gradient (resulting in depolariza-
tion), rather than by the pumping of protons. Like the BRs
and HRs, ChRs from various species (Nagel et al., 2002; Zhang
et al., 2008) are functional in neurons with a range of distinct
and useful intrinsic properties.
The single-component optogenetic palette available to neuro-
scientists now contains tools for four major categories of fast
excitation, fast inhibition, bistable modulation, and control of
intracellular biochemical signaling in neurons and other cell
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Figure 1. Basic Properties of Known Single-Component Optogenetic Tools with Published Spectral and Kinetic Information
(A) Single-component optogenetic tool families; transported ions and signaling pathways are indicated.
(B) Kinetic and spectral attributes of optogenetic tool variants for which both of these properties have been reported and for which minimal activity in the dark is
observed. Visible spectrum shown; not venturing into the ultraviolet is preferred, for safety and light penetration reasons, although the 450–470 nm peak probes
also can be excited very effectively with UV light (360–390 nm). Decay kinetics are plotted against peak activation wavelength only to demonstrate groupings
and classes over the range of spectral and temporal characteristics and the feasibility of dual channel control using tools that are well separated in the spectral
and temporal domains; see Table 1 for additional information and references. Kinetic data are not published for the proton pump Mac but the Mac action
spectrum peak 565 nm is identical to that of Arch (Chow et al., 2010). Opto-XR kinetics were obtained in vivo and should be taken only as an upper bound
since the assay involved a downstream measure (spiking). Decay kinetics are temperature dependent; all other reported values except ChRGR are recorded at
RT, with 50% decrease in toff expected at 37C. *Since ChRGR has only been studied at elevated (34C) T, we denote likely RT range for ChRGR shifted to the
right. Values for channelrhodopsin/fast receiver and channelrhodopsin/wide receiver (Wang et al., 2009) can be estimated at 7 and 14 ms, respectively; these are
not shown but respond at 470 nm and have not yet been functionally validated in neurons. L132C (CatCH) toff value was not measured in neurons, and its
properties may depend on other channels in the host cell as well as the host cell tolerance of, and response to, higher levels of elevated intracellular Ca2+
(Kleinlogel et al., 2011).
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Primertypes (Figure 1B, Table 1). This array of optogenetic tools, the
result of molecular engineering and genomic efforts, allows
experimental manipulations tuned for (1) the desired physiologic
effect; (2) the desired kinetic properties of the light-dependent
modulation; and (3) the required wavelength, power, and spatial
extent of the light signal to be deployed.
Fast Optogenetic Excitation for Neuroscience
Microbial opsin genes in some cases lead to expression of light-
inducible photocurrents when introduced into neurons, but to
date, optogenetic application of all of these genes has benefited
substantially from molecular modification. In neuroscience, after
initial demonstration (Boyden et al., 2005; Li et al., 2005; Nagel
et al., 2005; Bi et al., 2006; Ishizuka et al., 2006), a subsequent
widely used form of channelrhodopsin was generated bysubstituting mammalian codons to replace algal codons in
order to achieve higher expression levels (humanized ChR2 or
hChR2; Zhang et al., 2006; Adamantidis et al., 2007; Aravanis
et al., 2007; Zhang et al., 2007), and this process is now typically
applied to all new opsin genes. An important caveat is that
codon optimization and mutagenesis can lead to unanticipated
effects in different experimental systems, and an intervention
that gives rise to improved properties in mammalian neurons
(such as point mutation, codon optimization or membrane
trafficking modification) could in principle show impairment in
other properties (and unchanged or even impaired performance
in another cell or system). For example, introduction of the
H134R mutation into ChR2 was found to be of mixed impact,
improving currents 2-fold during prolonged stimulationNeuron 71, July 14, 2011 ª2011 Elsevier Inc. 11
Table 1. Single-Component Optogenetic Tools with Both Spectral and Kinetic Data Published
Opsin Mechanism Peak Activation l Off Kinetics (t, ms)* Kinetics References
Blue/Green Fast Excitatory
ChR2 Cation channel 470 nm 10 ms Boyden et al., 2005;
Nagel et al., 2003
ChR2(H134R) Cation channel 470 nm 18 ms Nagel et al., 2005;
Gradinaru et al., 2007
ChR2 (T159C) Cation channel 470 nm 26 ms Berndt et al., 2011
ChR2 (L132C) Cation channel 474 nm 16 ms* Kleinlogel et al., 2011
ChETAs:
ChR2(E123A)
ChR2(E123T)
ChR2(E123T/T159C)
Cation channel 470 nm (E123A)
490 nm (E123T)
4 ms (E123A)
4.4 ms (E123T)
8 ms (E123T/T159C)
Gunaydin et al., 2010;
Berndt et al., 2011
ChIEF Cation channel 450 nm 10 ms Lin et al., 2009
ChRGR Cation channel 505 nm 4-5 ms* (8-10ms) Wang et al., 2009;
Wen et al., 2010
Yellow/Red Fast Excitatory
VChR1 Cation channel 545 nm 133 ms Zhang et al., 2008
C1V1 Cation channel 540 nm 156 ms Yizhar et al., 2011a
C1V1 ChETA (E162T) Cation channel 530 nm 58 ms Yizhar et al., 2011a
C1V1 ChETA
(E122T/E162T)
Cation channel 535 nm 34 ms Yizhar et al., 2011a
Bistable Modulation
ChR2-step function
opsins (SFOs)
Cation channel 470 nm
activation / 590 nm
deactivation
2 s (C128T);
42 s (C128A)
1.7 min (C128S)
6.9 min (D156A)
29 min (128S/156A)
Berndt et al., 2009;
Bamann et al., 2010
Yizhar et al., 2011a
VChR1-SFOs Cation channel 560 nm
activation / 390 nm
deactivation
32 s (C123S)
5 min (123S/151A)
Yellow/Red Inhibitory
eNpHR3.0 Chloride pump 590 nm 4.2 ms Gradinaru et al., 2010
Green/Yellow Inhibitory*
Arch/ArchT Proton pump 566 nm 9 ms Chow et al., 2010
eBR Proton pump 540 nm 19 ms Gradinaru et al., 2010
Biochemical Modulation
Opto-b2AR [ Gs-protein signaling 500 nm 0.5 s Airan et al., 2009
Opto-a1AR [ Gq-protein signaling 500 nm 3 s Airan et al., 2009
Rh-CT(5-HT1A) [ Gi/o-protein signaling 485 nm 3 s Oh et al., 2010
bPAC [ cAMP 453 nm 12 s Stierl et al., 2011
BlaC [ cAMP 465 nm 16 s (50% decay) Ryu et al., 2010
*Decay kinetics are temperature dependent; values were taken from or estimated from published traces where available and necessary. Opto-XR
kinetics were obtained in vivo and should be taken only as an upper bound since the assay involved a downstreammeasure (spiking). All other reported
values except ChRGR are recorded at RT, with50% decrease in toff expected at 37C; since ChRGR has only been studied at elevated (34C) T, we
denote likely RT range for ChRGR in parentheses. Values for channelrhodopsin/fast receiver and channelrhodopsin/wide receiver (Wang et al., 2009)
were estimated at 7 and 14 ms, respectively, at 34C; these are not shown but respond at 470 nm and have not yet been functionally validated in
neurons. Kinetic data are not published for the proton pump Mac but the Mac action spectrum peak 565 nm is similar to that of Arch (Chow
et al., 2010). L132C (CatCH) toff value was not measured in neurons, and its properties may depend on other channels in the host cell as well as
the host cell tolerance of, and response to, higher levels of intracellular Ca2+ (Kleinlogel et al., 2011).
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Primeralthough at the expense of 2-fold slower channel-closure
kinetics and consequent poorer temporal precision (Nagel
et al., 2005; Gradinaru et al., 2007); nevertheless, like hChR2,
hChR2(H134R) can drive precise low-frequency spike trains12 Neuron 71, July 14, 2011 ª2011 Elsevier Inc.within intact tissue and is widely used. Similarly, modification
of the Thr159 position (T159C; Berndt et al., 2011) and the
Leu132 position (L132C; Kleinlogel et al., 2011) were found to
increase photocurrent magnitude with a concomitant slowing
Neuron
Primerin channel off-kinetics. Notably, modified ChRs have been
developed with a chimera-based approach (Wang et al., 2009;
Lin et al., 2009; Yizhar et al., 2011a), resulting in both quantita-
tively stronger photocurrents and reduced desensitization in
cultured neurons.
A substantially red-shifted channelrhodopsin (VChR1) that can
be excited by amber (590 nm) light, whichdoes not affect ChR2at
all, was identified by genomic strategies and validated in cultured
neurons (Zhang et al., 2008), raising the possibility of combinato-
rial excitation in vivo (Yizhar et al., 2011a). Most channelrhodop-
sins described to date have a relatively low single-channel
conductance and broad cation selectivity (Nagel et al., 2003;
Zhang et al., 2008; Lin et al., 2009; Tsunoda and Hegemann,
2009; Gunaydin et al., 2010), but cellular photocurrents can be
vastly improved with molecular engineering strategies, including
for VChR1 (e.g., Yizhar et al., 2011a). With the exception of the
recently reportedL132Cmutant (Kleinlogel et al., 2011), channelr-
hodopsins generally give rise to only small Ca2+ currents at
physiological Ca2+ concentrations, and increases in cytosolic
Ca2+ due to channelrhodopsin activation result chiefly from
activation of endogenous voltage-gated Ca2+ channels via
membrane depolarization and neuronal spiking (Zhang and Oert-
ner, 2007), which also occur to varying extents with different
native depolarization processes. Second- and also third-order
conductances (e.g.,Ca2+-gatedpotassiumandchloridecurrents)
must nevertheless be kept in mind, especially when higher Ca2+-
conducting channelrhodopsins are employed, as these will influ-
ence light-evokedactivity in amanner thatmay vary fromcell type
tocell type; for example,different cells (or evendifferent regionsof
the same cell) may elicit, tolerate, or respond to higher levels of
Ca2+ differently. Recent modeling work in which photocurrent
responses were integrated with a Hodgkin-Huxley neuron model
(Grossman et al., 2011) will be potentially expandable to include
thesesecond-order conductancesandpredict cellular responses
under various stimulation paradigms.
Bistable behavior has been obtained with molecular engi-
neering of ChRs, generating a distinct class of opsin-based tools
in which mutations in cysteine-128 and aspartate-156 in ChR2
significantly prolong the photocycle (Berndt et al., 2009; Bamann
et al., 2010). While the conductance of wild-type ChR2 deacti-
vates with a time constant of 10 ms upon light cessation, the
ChR2(C128X) mutants are vastly slower. For example, in the
C128T, C128A, and C128S mutants, photocurrents decay
spontaneously with time constants of 2 s, 42 s, and 100 s,
respectively (Berndt et al., 2009). Termination of this stable blue-
light triggered photocurrent is still possible by applying a pulse
of yellow light (560–590 nm; Berndt et al., 2009). Mutant genes
of this class are termed step-function opsin (SFO) genes, since
they enable bistable, step-like control of neuronal membrane
potential that can bring cells closer to action potential threshold
and increase the probability of spiking to endogenous synaptic
inputs (Berndt et al., 2009). Two crucial distinct properties of
SFOs by comparison with conventional ChRs are (1) orders-of-
magnitude increased effective cellular light sensitivity, which
results fromaccumulation of open channels during the light pulse,
leading to larger volumesof tissue recruited in vivo for a given light
intensity (Berndt et al., 2009; Diester et al., 2011); and (2) the
asynchronousnatureofSFO-mediatedneuronal activation,whichdoes not entrain all the expressing neurons into a single pattern
dictated by light delivery (Berndt et al., 2009), a property that
maybepreferable in someapplications (but not in others requiring
synchronous or precisely timed spikes).
SFOs have recently been shown to deliver bistable optoge-
netic control in C. elegans neurons and muscle cells (Schultheis
et al., 2011) and in the brains of awake, behaving primates
(Diester et al., 2011). Additional and combinatorial mutagenesis
based on these initial principles has led to additional SFOs
(Bamann et al., 2010; Yizhar et al., 2011a), with time constants
of deactivation up to 30 min (Yizhar et al., 2011a). With these
stabilized SFOs, targeted neurons can in principle be ‘‘stepped’’
to a stable depolarized resting potential, which could be followed
by removal of the light source and initiation of behavioral or
physiological experimentation in the complete absence of light
or other hardware. Moreover, the use of long low-intensity light
pulses (in the setting of the steady photon-integration properties
of cells expressing the stable SFOs) could allow elimination of
variability of recruitment of cells in vivo attributable to variations
in light intensity experienced, since the full population of opsin-
expressing cells even in a large volume of tissue could be
brought to saturating photocurrent levels over time.
While these tools afford experimental opportunities, an impor-
tant caveat of this approach is that it must be validated in each
system to quantify the effect on targeted cells. The published
SFOs have slower activation kinetics that do not tend to directly
elicit spikes or drive neurons into a state of depolarization block
(the latter of which could give rise to a paradoxical inhibition
rather than excitation of the targeted cells), but studies involving
SFOs (indeed involving any optogenetic intervention) should still
be accompanied by electrophysiological validation at the corre-
sponding experimental time point (matching opsin expression
levels) so that the effect on the targeted cell and tissue may be
understood for proper interpretation of experimental results.
Here, the SFOs, and indeed all optogenetic tools, offer a class
of validation not typically possible with electrical stimulation,
since with electrical stimulation it remains unclear precisely
how the targeted region is responding due to the difficulties
associated with electrical recording in the setting of electrical
stimulation artifacts.
None of the ChRs described above were initially shown to
directly evoke reliable spiking above 40 Hz, while many neuronal
cell types and physiological processes involve or require high-
frequency spike trains (>40 Hz). Even the seemingly fast off-
kinetics of wild-type ChR2 (t 10 ms), and certainly those of
H134R (t 20 ms), are insufficient for precise control at high
spike rates, a phenomenon that may be compounded by the
further depolarization-dependent slowing of deactivation ob-
served for most ChRs (Berndt et al., 2011). An important group
of relevant neurons are the fast-spiking inhibitory parvalbumin-
expressing interneurons, which in cortex are thought to be
involved in generation of oscillatory rhythms and synchronization
across brain regions (Freund, 2003). Activation of these neurons
with wild-type ChR2 is not sufficiently precise above 40 Hz, due
to spike doublets, plateau potentials, and temporal nonstatio-
narity in the form of missed spikes late in sustained high-
frequency light pulse trains (which may result from the failure
of full membrane repolarization and consequent insufficientNeuron 71, July 14, 2011 ª2011 Elsevier Inc. 13
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Primervoltage-dependent deinactivation of voltage-gated sodium
channels; Gunaydin et al., 2010).
Modifying ChR2 residue glutamate 123 to threonine or alanine
(T/A) was found to accelerate channel closure kinetics from
10 ms to 4 ms, at the expense of moderately decreased
photocurrent magnitude, a change that significantly increased
the fidelity of fast optogenetic control (Gunaydin et al., 2010).
These E123 variants can be combined with other modifications
such as the H134R or T159C mutations (Gunaydin et al., 2010;
Berndt et al., 2011) or membrane trafficking modifications (Gra-
dinaru et al., 2008, 2010; Zhao et al., 2008). The E123 mutations
appear unique thus far among channelrhodopsin mutations as
they eliminate the sensitivity of channel kinetics to membrane
potential, whether alone or in combination with other mutations
(H134R and T159C; Berndt et al., 2011). Once this nonlinear
and nonstationary effect is eliminated, the channel response to
a light pulse can be more predictable and easier to model. These
fast variants therefore addressmany dimensions of signal fidelity
that are degraded with high frequency stimulation in wild-type
ChR2. Opsins of this class (E123 mutations alone or in combina-
tion with other modifications; Gunaydin et al., 2010) are termed
ChETAs (ChR E123T/A). Notably, fast-spiking activity is not
unique to the parvalbumin-expressing neurons, as many neuron
types in the brain can fire at > 40 Hz; moreover, not only fast-
spiking cells may benefit from ChETA usage, as the reduced
occurrence of extra spikes (along with reduced spurious pro-
longed depolarizations) with ChETA can enhance the fidelity of
evoked neural codes even in non-fast-spiking cells. ChETA tools
have been shown to deliver improved performance within intact
mammalian brain tissue (Gunaydin et al., 2010), while at the
same time, a major caveat is that faster deactivation tends to
translate into reduced effective cellular light sensitivity for long
pulses of light, since fewer channels remain or accumulate in
the open (conducting) state.
Pharmacological, optogenetic, and electrical stimulation will
appear different (by comparison with native synaptic drive) to
the directly targeted cells at the site of stimulation, since conduc-
tance changes, ion fluxes, and membrane potential changes will
not originate precisely at the physiological pattern of synapses or
receptor sites (although dendritic opsin targeting strategies may
be relevant here; Gradinaru et al., 2007; Greenberg et al., 2011),
nor be necessarily timed at physiological intervals relative to
other events and cellular responses such as spiking. Any of these
methods could also affect intracellular membranes (such as the
endoplasmic reticulum, nuclear membranes, synaptic vesicles,
and mitochondria). This concept must be kept in mind when
experimental stimulation methods are used to study processes
within single cells, more so than in the increasingly common
study of downstream (postsynaptic) circuit or systems-level
questions. Moreover, while optogenetic activation represents
an important advance over electrical stimulation in its specificity,
certain fundamental differences between optogenetic and elec-
trical activation should be taken into consideration (Gradinaru
et al., 2009; Llewellyn et al., 2010; Diester et al., 2011). Consider
two equivalent experiments, one using electrical microstimula-
tion of a targeted region in vivo, and another in which a channelr-
hodopsin gene is expressed in local neurons while an optical
fiber is placed above the structure. Both types of stimulation14 Neuron 71, July 14, 2011 ª2011 Elsevier Inc.will lead to action potentials in the targeted region. In the optoge-
netic experiment, the targeted cells and their axons will first be
selectively activated, importantly followed by activation of
synapses, cells, and circuits that are connected downstream
of the targeted cells; moreover, when photosensitive axons are
directly illuminated as in a projection-targeting experiment,
smaller-caliber fibers are likely to be recruited at the lowest
stimulation levels before larger-caliber fibers (orderly or physio-
logical recruitment; Llewellyn et al., 2010). In contrast, the
electrical experiment may first lead to spiking in diverse local,
afferent, and passing axonal fibers (recruiting larger-caliber
axons first in the phenomenon of recruitment reversal, with asso-
ciated orthodromic and antidromic propagation even to nonlocal
somata; Histed et al., 2009; Llewellyn et al., 2010), a property
that may explain aspects of electrical deep brain stimulation
(DBS) function in the treatment of Parkinson’s Disease (Gradi-
naru et al., 2009) as well as microstimulation function in systems
neuroscience.
While the specificity of optogenetics presents an opportunity
to understand precisely how cells and circuits give rise to
nervous system function, experimental effects will depend on
the type of neuron and cellular compartment targeted as well
as the stimulation parameters employed (pulse frequency,
duration, amplitude, and other factors, just as with electrical
stimulation). Moreover, opsin choice (e.g., ChETA versus
H134R or L132C) could affect the extent to which paired-pulse
or plasticity effects are elicited in a manner distinct from electri-
cal stimulation, especially in experiments where light is directly
applied to the axons and the ChR therefore directly influences
presynaptic terminal ion flux; in contrast, where light is delivered
directly to the soma and propagating sodium action potentials
are generated, the resulting presynaptic bouton (and down-
stream postsynaptic) spikes may look indistinguishable from
those generated by native electrical spike generation mecha-
nisms in terms of ion flux and kinetics.
Fast Optogenetic Inhibition for Neuroscience
It must be recognized that delivering gain of function with
a targeted channelrhodopsin only demonstrates that a particular
pattern of activity in a defined population is causally sufficient for
a circuit or behavioral property. But in principle multiple different
cell populations could give rise to the same circuit or behavioral
property, not necessarily only the cells that normally give rise
to the effect in a naturalistic or physiological setting for the
organism. For this reason, loss-of-function (inhibitory) tools are
also important in optogenetics, for testing necessity of activity
in the targeted cell population.
In a screen for hyperpolarizing fast optogenetic tools, the
halobacterial HR (which gives rise to electrogenic chloride influx)
showed excessive desensitization (Zhang et al., 2007). However,
the homologous gene from Natronomonas pharaonis (NpHR;
Lanyi and Oesterhelt, 1982; Scharf and Engelhard, 1994; Sato
et al., 2005) gave rise to suitably stable outward (hyperpolarizing)
currents (Zhang et al., 2007) with photocurrent peak 590 nm
(a wavelength at which ChR2 shows no response at all, enabling
independent activation of ChR2 and NpHR to bidirectionally
modulate activity; Figure 1). Unlike the excitatory channelrho-
dopsins, NpHR is a true pump and requires constant light in
order to move through its photocycle. Moreover, although
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freely moving worms and in mammalian brain slices (Zhang
et al., 2007) as well as cultured neurons (Zhang et al., 2007;
Han and Boyden, 2007), several years passed before mamma-
lian validation of any inhibitory optogenetic tool was obtained
by successful application to behavioral studies in intact
mammals (Witten et al., 2010; Tye et al., 2011), due tomembrane
trafficking problems that required additional engineering (Gradi-
naru et al., 2008, 2010; Zhao et al., 2008).
At high expression levels, NpHR-EYFP-expressing cells were
found to show accumulations of intracellular fluorescence that
colocalized with endoplasmic reticulum (Gradinaru et al., 2008).
Addition of an ER export motif from the Kir2.1 potassium channel
(ER2—identified after a screen of many possible corrective
motifs; Gradinaru et al., 2008) improved the surface membrane
localization of NpHR and yielded eNpHR2.0 (Gradinaru et al.,
2008; Zhao et al., 2008), with higher currents suitable for use in
intact rodent tissue (Sohal et al., 2009; Tønnesen et al., 2009)
as well as in human and nonhuman primate tissue (Busskamp
et al., 2010; Diester et al., 2011). Next, eNpHR3.0, which addi-
tionally contains a neurite trafficking sequence from the Kir2.1
potassium channel, showed further enhanced photocurrents
(nanoampere scale at moderate light intensities, < 5 mW/mm2)
that can be used to drive inhibition by yellow- or far-red-shifted
wavelengths (up to 680 nm at the infrared border; Gradinaru
et al., 2010).
eNpHR3.0 ultimately enabled the loss-of-function side of
optogenetics for behavior in freely moving mammals (Witten
et al., 2010; Tye et al., 2011), complementing the engineered
channelrhodopsins that had enabled gain-of-function in freely
moving mammals (Adamantidis et al., 2007). eNpHR3.0 was first
used along with bilateral optical fiber devices to inhibit the
cholinergic neurons of the nucleus accumbens and elucidate
a causal role for these rare cells in implementing cocaine
conditioning in freely moving mice, which appears to operate
via enhancing inhibition of inhibitory striatal medium spiny
neurons (Witten et al., 2010). eNpHR3.0 was also used in
a two-fiber approach to inhibit a specific intra-amygdala projec-
tion in freely moving mice, implicating a defined neural pathway
in aspects of anxiety and anxiolysis (Tye et al., 2011). Given the
highly redundant and parallel architecture of neural circuitry, in
general it may be more challenging to elicit loss-of-function
than gain-of-function circuit effects; indeed, for loss-of-function
experiments, as in these two studies, it is advisable to employ
bilateral fibers to target corresponding structures in both hemi-
spheres, rather than the single unilateral fiber in each test subject
that typically suffices for gain-of-function work. These studies
also depend on photocurrent stability of inhibitory opsin function
on mammalian behavioral timescales.
The crystal structure of NpHR has been published (Kouyama
et al., 2010) and illustrates that this protein has a high degree
of structural homology within the retinal binding pocket with
the proton pumps such as bacteriorhodopsin. In 2010 two
groups explored the use of proton pumps (Mac, Arch, and
eBR) as optogenetic tools (Chow et al., 2010; Gradinaru et al.,
2010), finding robust efficacy but leaving open questions of
long-term tolerability and functionality of proton-motive pumps
in mammalian neurons. One caveat is the extent to which pump-ing of large proton fluxes to the extracellular space (especially in
juxtamembranous compartments difficult to assess) might have
unwanted or non-cell-type-specific effects; such an effect might
manifest only under conditions where many (but not all) local
neurons are expected to be opsin expressors, and might be
detected in this case (e.g., in extracellular recordings) as optoge-
netic inhibition of spiking in nonexpressing cells with a slower
mean timecourse than expected from the millisecond-scale
kinetics of the pumps. Indeed, the inhibitory pumps (including
chloride pumps) are typically driven with continuous light (to
avoid rebound excitation), which could deter recovery of ionic
or pH imbalances; in contrast, channelrhodopsins are permeant
to cations including protons but are driven most typically in
neuroscience experiments by well-separated pulses of light.
Finally, caution must be exercised, particularly with steady
light, to avoid heating of tissue. It is therefore important to
consider the light intensities required for optogenetic inhibition
at a particular photocurrent value, keeping in mind that to
compensate for scattering losses, in vivo light is typically deliv-
ered to the tissue at 100-fold or more higher intensity than
required at the target cell (Aravanis et al., 2007; Gradinaru
et al., 2010). To avoid toxicity while maintaining efficacy, we
recommend selecting inhibitory opsins that allow delivery of >
400 pA of current at irradiance values of < 10–20 mW/mm2 at
the target cell, and we return to the issue of heating and irradi-
ance levels below. While nanoampere-scale inhibitory currents
sufficient for mammalian behavioral effects already can be re-
cruited at < 5 mW/mm2 (Gradinaru et al., 2010), ongoing engi-
neering and discovery of known and existing opsins will continue
to expand the optogenetic toolkit in this direction as well. Just as
with NpHR as described above, modifying Arch by providing the
ER2 motif for endoplasmic reticulum export—initially found by
Gradinaru et al. (2008) and Zhao et al. (2008) to promote micro-
bial opsin expression and function in neurons—allows genera-
tion of larger proton currents (J. Mattis, personal communica-
tion), and this membrane trafficking modification principle thus
far appears to be a generalizable means (Gradinaru et al.,
2010) by which heterologous membrane expression of novel
microbial opsins for optogenetics in neuroscience may be
achieved. Moreover, diverse opportunities to develop or
discover new optogenetic tools exist given the large diversity
of microbial opsin genes in nature, and since 2008 screens of
genomic data have led to identification of many additional tools
(e.g., Zhang et al., 2008; Chow et al., 2010; Gradinaru et al.,
2010; Yizhar et al., 2011a).
Tools for Modulation of Biochemical Signaling
The microbial (type I) opsin genes described above encode
strictly ion flow modulators, which control the excitability of
a neuron by directly manipulating itsmembrane potential—either
bringing the membrane potential nearer to or above the
threshold for generating an action potential or hyperpolarizing
the cell and thereby inhibiting spiking. While this approach has
advantages of speed and precision, in some experimental proto-
cols temporally precise modulation of intracellular processes
may be necessary.
Vertebrate rhodopsin (such as the light-sensing protein in the
mammalian eye) is both an opsin (type II), in that it is covalently
bound to retinal (in the cis configuration) with functionmodulatedNeuron 71, July 14, 2011 ª2011 Elsevier Inc. 15
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(GPCR), in that it is coupled on the intracellular side to G protein
signaling. Expressing vertebrate rhodopsins alone can confer
light sensitivity, which can be observed as a slow inhibitory (Li
et al., 2005) or excitatory (Melyan et al., 2005) modulation. Since
these heterologous expression experiments are conducted in
the absence of the native G protein (e.g., transducin), the
rhodopsin must engage in novel interactions with unknown G
proteins not normally linked to rhodopsin that are present in
the host cell, and effects on cellular properties may therefore
depend on the specific G protein pathways present in each
host cell type. Optogenetic recruitment of well-defined biochem-
ical signaling events can be achieved in generalizable fashion
by constructing chimeras (Kim et al., 2005) between vertebrate
rhodopsin and conventional ligand-gated GPCRs that can serve
as single-component neural control tools (Airan et al., 2009; Oh
et al., 2010), such as the dopaminergic, serotonergic, and adren-
ergic receptors that play important roles in neurotransmission
and neuromodulation. This type II approach can capitalize
upon the retinoids present within vertebrate tissues, as identified
in the course of microbial (type I) opsin work (Deisseroth et al.,
2006; Zhang et al., 2006). When used as optogenetic tools these
type II fusion proteins are referred to as optoXRs, which allow
for optically controlled intracellular signaling with temporal
resolution suitable for modulating behavior in freely moving
mice (Airan et al., 2009).
The speed and cellular precision that define biochemical
optogenetic techniques, as with electrical optogenetic tech-
niques, provide opportunities not achievable with pharmacolog-
ical and genetic tools. Moreover, optoXRs (Airan et al., 2009) can
leverage the optical interfaces (laser diode-fiberoptic devices;
Aravanis et al., 2007) previously developed for type I work in
freelymovingmammals. Indeed, control of biochemical signaling
representsanactiveand rapidly growingdomainof optogenetics.
Optical control over small GTPases has been described in
cultured cells by several different laboratories (Levskaya et al.,
2009; Wu et al., 2009; Yazawa et al., 2009) using optically modu-
lated protein-protein interactions. Finally, microbial adenylyl
cyclases have been recently described with lower dark activity
than earlier microbial cyclases, and since they employ a flavin
chromophore native to vertebrate tissues, these tools appear
suitable for single-component optogenetic control (Ryu et al.,
2010; Stierl et al., 2011). While these newer tools have not yet
been shown to display single-component functionality in freely
moving mammals, such capability is expected in systems where
the required chromophores are present. Together, these experi-
ments have extended optogenetic capability to essentially every
cell type (even nonexcitable cells) in biology, and have success-
fully leveraged optical hardware and targeting techniques
previously developed for type I optogenetic experiments.
Associated Enabling Technologies for Optogenetics
in Neuroscience: Opsin Targeting
While optogenetic tools are continuously being optimized for
efficient transcription, expression, and safety, a successful
neuroscience experimental paradigm additionally requires
specific in vivo targeting of the optogenetic tool. In this section
we review generalizable in vivo delivery and targeting strate-16 Neuron 71, July 14, 2011 ª2011 Elsevier Inc.gies. Major categories include (1) viral promoter targeting, (2)
projection targeting, (3) transgenic animal targeting, and (4)
spatiotemporal targeting—subsets of which may be combined
for further increased specificity.
Targeting with Viruses
Viral expression systems have numerous advantages for
optogenetics, including rapidity and flexibility of experimental
implementation, potency linked to high gene copy number,
and capability for multiplexing genetic and anatomical specificity
as described below. Indeed, viral vectors currently represent
the most popular means of delivering optogenetic tools to intact
systems. For example, lentiviral vectors (LV; Dittgen et al., 2004)
and adeno-associated viral vectors (AAV; Monahan and Samul-
ski, 2000) have been widely used to introduce opsins into mouse
(e.g., Adamantidis et al., 2007; Petreanu et al., 2009; Haubensak
et al., 2010; Ciocchi et al., 2010; Lobo et al., 2010; Kravitz et al.,
2010), rat (e.g., Aravanis et al., 2007; Gradinaru et al., 2009; Lee
et al., 2010), and primate (Han et al., 2009; Busskamp et al.,
2010; Diester et al., 2011) neural tissues. These vectors have
achieved high expression levels over long periods of time with
little or no reported adverse effects. LV may be easily produced
using standard tissue culture techniques (Zhang et al., 2007,
2010), while AAV may be more challenging to produce within
standard laboratory environments and can be produced either
by individual laboratories (e.g., using kits such as Virapur) or
through core virus production facilities (e.g., University of Penn-
sylvania, Stanford University, and University of North Carolina,
where we have arranged a process by which useful quantities
of live virus for experiments may be obtained economically
from much larger preparations of commonly used optogenetic
viruses). AAV-based expression vectors display low immunoge-
nicity and offer the advantage of viral titers that result in larger
transduced tissue volumes compared with LV. Additionally,
AAV is considered safer than LV since currently available strains
do not broadly integrate into the host genome and are rated as
BSL1, compared with the BSL2+ LV. Both viruses support
pseudotyping techniques that in principle enable a range of
cell-type tropisms and transduction mechanisms. The high
multiplicity-of-infection achieved with LV and AAV is particularly
useful for optogenetics, as high copy numbers of opsin genes
are required to ensure robust photocurrent responses in vivo.
Among the most widely used AAV vectors are recombinant
AAV2 (rAAV2) vectors pseudotyped with various serotype pack-
aging systems (e.g., rAAV2/2 or rAAV2/5, referred to simply as
AAV2 or AAV5 here). AAV2 differs fromAAV5 in the degree of viral
spread, in both rodents (Paterna et al., 2004) and primates (Mar-
kakis et al., 2010). A microliter-scale volume of AAV5 injected
into mouse hippocampus will diffuse and transduce neurons
through much of the entire structure. In contrast, injections of
AAV2 in the CNS can result in a relatively restricted expression
pattern and thus may be suitable for experiments where local
expression is desirable (Burger et al., 2004). LV is even more
restricted in its diffusion in vivo and can be used to target
subfields of a structure such as the CA1 region of the mouse
hippocampus. Differences in trafficking might be related to
relative distribution of binding partners in the neuropil; AAV2 is
known to transduce neurons via proteoglycan molecules, using
FGF receptors and integrins as coreceptors (Summerford and
Table 2. Characterized Viral Promoters for Specific Optogenetic Targeting
Vector Promoter (serotype) Size Organism Cell-Type Specificity References
Lentivirus
EF1a 1.2 Kb Rat, mouse Neuron-specific only in LV* Jakobsson et al., 2003
CMV 0.6 Kb Rat, mouse Nonspecific (8.6% glia
expressing transgene)
Blo¨mer et al., 1997;
Jakobsson et al., 2003;
Dittgen et al., 2004
Human SynapsinI
(hSynI)
0.5 Kb Rat, mouse Panneuronal, but a tropism
for excitatory cells in LV
Dittgen et al., 2004;
Nathanson et al., 2009b;
Diester et al., 2011
CaMKIIa 1.3 Kb Macaque,
rat, mouse
Excitatory neurons in cortex
and hippocampus
Mayford et al., 1996;
Dittgen et al., 2004;
Aravanis et al., 2007
hGFAP 2.2 Kb Rat, mouse Astrocytes Brenner et al., 1994;
Jakobsson et al., 2003;
Gradinaru et al., 2009;
Gourine et al., 2010
TPH-2 2 Kb Rat Raphe serotonergic neurons Benzekhroufa et al., 2009b**
Adeno Associated Virus
CaMKIIa
(AAV5)
1.3 Kb Macaque,
rat, mouse
Excitatory CaMKIIa neurons
in cortex, amygdala.
Lee et al., 2010;
Tye et al., 2011
hSynI
(AAV2)
0.5 Kb Macaque,
rat, mouse
Panneuronal, but a tropsim
for inhibitory cells at low titers
Nathanson et al., 2009b;
Diester et al., 2011
hThy1 (AAV5) 5 Kb Macaque Panneuronal Diester et al., 2011
fSST
(AAV1)
2.6 Kb Macaque,
rat, mouse
Inhibitory neurons
(no subtype specificity)
Nathanson et al., 2009a
hGFAP
(AAV5, AAV8)
2.2 Kb Rat Astrocytes Lawlor et al., 2009;
Lee et al., 2010
MBP (AAV8) 1.35 Kb Rat Oligodendrocytes Lawlor et al., 2009
SST (AAV2) 2 Kb Rat preBo¨tzinger C somatostatin
neurons
Tan et al., 2008
Specificity might vary with organism and brain region. Specificity needs to be evaluated for each individual construct and vector.
* Some nonspecific promoters, such as EF1a, can appear neuron specific in lentivirus but not in other vectors.
** This study also uses a novel IRES-based single-vector Gal4/p65 amplification system, which might be applicable in other weak promoters.
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AAV5 binds sialic acid and enters neurons through PDGF recep-
tors (Di Pasquale et al., 2003). Additional AAV serotypes are
continually undergoing characterization (Broekman et al., 2006;
Lawlor et al., 2009), with a reported diversity of > 120 different
AAV subtypes yet to be tested. Notably, molecular engineering
is being applied to the capsid proteins of AAV to generate novel
tropisms for a wider range of cell-type specificity with hybrid
AAVs (Choi et al., 2005; Markakis et al., 2010), and the growing
interest in the use of AAV vectors for gene therapy will undoubt-
edly facilitate the characterization of these new vectors and yield
improved targeting strategies for optogenetics.
Crucially, with viral expression, targeting specificity can arise
from multiple intersecting mechanisms. For example, specificity
for a selected neuronal population can be conferred by idiosyn-
cratic viral tropisms for different cell types (Burger et al., 2004;
Nathanson et al., 2009b), as well as by cell-type-specific
promoters used to drive expression of the transgene (Brenner
et al., 1994; Mayford et al., 1996; Blo¨mer et al., 1997; Jakobsson
et al., 2003; Dittgen et al., 2004; Nathanson et al., 2009a). In
a comparison between expression of transgenes under thesame promoter with AAV2 or lentivirus, lentiviral vectors were
biased to transduction of excitatory neurons whereas low-titer
AAV2 vectors expressed more in inhibitory neurons in mouse
somatosensory cortex (Nathanson et al., 2009b). Promoters
that are not neuron specific but do drive robust expression in
neurons (such as EF1a), when expressed using AAV or VSVG-
pseudotyped LV, have been used for opsin expression in
mammalian brains (Deisseroth et al., 2006; Zhang et al., 2006).
Only a few cell-type-specific promoter fragments are small
enough to be packaged with the AAV or LV viral genome along
with an opsin (Table 2), while retaining useful expression speci-
ficity properties. Astrocyte-specific promoter fragments (i.e.,
GFAP) have been characterized (Brenner et al., 1994) that can
drive specific expression of transgenes in astrocytes (excluding
neurons) both with VSVG-pseudotyped LV (Jakobsson et al.,
2003) and with AAV (serotypes 8 and rh43; Lawlor et al., 2009);
these have now been applied for optogenetic experiments
(Gradinaru et al., 2009; Gourine et al., 2010) using the low Ca2+
flux through the ChR channel to trigger Ca2+ waves and activate
astroglial signaling. The human Synapsin I (Nathanson et al.,
2009b; Diester et al., 2011) and human Thy1 (Diester et al.,Neuron 71, July 14, 2011 ª2011 Elsevier Inc. 17
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Figure 2. Targeting Optogenetic Tools In Vivo
(A) Direct stimulation of neuronal cell bodies is achieved by injecting virus at the target region and then implanting a light-delivery device above the injected region.
Even this simple experiment can provide specificity with viruses that will not transduce afferent axons and fibers of passage.
(B) Additional cell-type specificity is attained either by cell-type-specific promoters in the viral vector or via a recombinase-dependent virus, injected in
a transgenic animal expressing a recombinase such as Cre in specific cells, leading to specific expression of the transgene only in defined cell types.
(C) Projection (axonal) targeting is achieved by viral injection at the region harboring cell bodies, followed by implantation of a light-delivery device above the
target region containing neuronal processes from the virally transduced region; in this way cell types are targeted by virtue of their projections.
(D) Projection termination labeling is a more refined version of projection targeting, in which cells are targeted by virtue of synaptic connectivity to the target
region and likely excluding cells with axons simply passing through the region. Transcellular labeling using a recombinase-dependent system is shown. Viruses
expressing Cre fused to a transneuronal tracer (lectin) are delivered at the synaptic target site, and a Cre-dependent virus is injected into the region with cell
bodies. Cells that project to the Cre-injected area express the Cre-dependent virus and become light sensitive. This can also be achieved with axon terminal-
transducing viruses although without control over the postsynaptic cell type.
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neurons (excluding glia) in a range of systems from rodent to
primate (see Table 2).
It remains a major challenge to identify neuron-type-specific
promoter fragments small enough to be packaged into viral
payloads, certainly in primate tissues but also in rodents and
other experimental systems. Several inhibitory neuron-specific
promoters have been characterized, although these are not
specific to subsets of inhibitory cells (Nathanson et al., 2009a;
Table 2). For broad excitatory neuron targeting, the Ca2+/
calmodulin-dependent kinase II alpha (CaMKIIa) promoter has
been shown to express mainly in excitatory neurons in cortex
and hippocampus (Dittgen et al., 2004), and for many years
has been applied for optogenetic control in a range of systems
(Aravanis et al., 2007; Zhang et al., 2007; Han et al., 2009; Sohal
et al., 2009; Johansen et al., 2010; Lee et al., 2010). Finally, in
certain systems, specific virus-compatible promoters for hypo-
cretin neurons, serotonin neurons, and somatostatinergic
neurons have been described (Adamantidis et al., 2007; Tan
et al., 2008; Benzekhroufa et al., 2009a, 2009b; Tan et al.,
2010; Table 2). An important caveat, however, is that promoter
specificity observed in one region of organism may not hold in
other tissues or organisms, and promoter and tropism strategies
are not truly generalizable. Additionally, promoter specificity
must be accompanied by viral access: a given neuron must
both express the viral receptor and the promoter in order to be
specified in this manner. Where available, each promoter must
be characterized for cell-type specificity within the context of
the chosen viral vector, organism, and brain region.
For simple optogenetic applications with small promoters,
such as the expression of an opsin gene tagged with a fluores-
cent protein, AAV vectors are sufficient. However, expression
of larger genes and larger promoters, or coexpression of more
than one optogenetic tool, requires careful consideration when
choosing the appropriate vector. The main challenge in
achieving specific expression with viral targeting is that the
genome size contained in a viral capsid is limited, depending
on the virus type and serotype. For example, LV particles can
carry a genome of up to 9 kb (Kumar et al., 2001), including the
regulatory elements and viral genes encoded within. AAV-based
vectors are generally restricted to a genome size of 4.7 kb,
although new methods might facilitate expression of larger
genomes (Dong et al., 1996, 2010). For expression of even larger
genomes (e.g., with larger promoter fragments or transgenes),
adenoviral vectors can carry up to 27 kb of geneticmaterial (Sou-
dais et al., 2004). Herpes simplex-based vectors (HSV; Lilley
et al., 2001; Lima et al., 2009; Covington et al., 2010; Lobo
et al., 2010) also have greater carrying capacity and offer the
potential for transducing axon terminals more efficiently than
LV or most AAV serotypes, although consistency and toxicity
are concerns for HSV approaches (Fink et al., 1996). This
axonal-transduction property (shared with rabies viruses, pseu-
dotyped LVs, some AAVs, and pseudorabies viruses (Kaspar
et al., 2002; Burger et al., 2004; Kato et al., 2007; Callaway,(E) Expression of two opsins with different characteristics in one brain region usi
somata is performed using two different wavelengths designed to minimize cros
(F) Projections from two different brain regions are differentially stimulated with t2008; Miyamichi et al., 2011; Kato et al., 2011) can be either
a feature or a bug in a given optogenetic experimental paradigm.
This property when utilized diminishes one of the valuable spec-
ificities of virus-based optogenetics, which has been confine-
ment of opsin gene transduction to local cell bodies without
the confound of transducing (and photosensitizing) incoming
afferents (e.g., Lee et al., 2010). On the positive side, such ‘‘retro-
grade’’ transduction provides one means for targeting neurons
based on connectivity (although other methods described below
exist to achieve this goal).
As noted above, relying on idiosyncratic known viral tropisms
or finding suitable virus-borne promoter fragments is not
currently available for optogenetic control of most neuronal
subtypes. However, the strategy of designing viruses that can
leverage the large and rapidly growing armamentarium of animal
lines that express exogenous recombinases only in defined cell
types (driver lines, which can fully capitalize on enormous native
promoter/enhancer regions rather than the small fragments
which fit into viruses) offers an expanded range of opsin targeting
strategies (Figure 2B; see Table 3 for driver lines used in optoge-
netic studies). New driver lines are continually added to the avail-
able repertoire by groups such asGENSAT and the Allen Institute
for Brain Science. Successfully utilizing a recombinase driver line
requires efficient packaging of the genetic material to be ex-
pressed into a recombinase-dependent system conferring the
two properties of (1) very low leak (background) of opsin expres-
sion in non-recombinase-expressing cells, and (2) very high re-
combinase-induced opsin expression—all within the viral back-
bone.
Several potential different recombinase-dependent viral
vector designs have emerged (Kuhlman and Huang, 2008;
Zhang, 2008; Atasoy et al., 2008; Sohal et al., 2009), and a Cre
recombinase-dependent double-floxed inverted opsin gene in
AAV under the EF1a promoter (Zhang, 2008; Sohal et al., 2009)
or the CAG promoter (Atasoy et al., 2008) was ultimately found
to provide a suitable combination of strength and specificity to
enable behaviorally significant optogenetic gain or loss of func-
tion within the constraints of the freely moving mammal system
(Tsai et al., 2009; Aponte et al., 2011). Not only is this strategy
versatile in the sense that it can be applied at will to the large
and growing pool of Cre driver lines (e.g., Gong et al., 2007),
soon to include rat as well as mouse lines, but this approach is
also by design expandable along new dimensions that enable
combinatorial experiments (Figure 2). First, other recombinases
such as Flp or Dre may be used to construct orthogonal driver
lines that can be crossed with Cre driver lines while the same
low-leak, high-potency recombinase-dependent AAV design is
theoretically adaptable for these other recombinases as well.
Second, promoter fragments may be used at the same time in
place of the EF1a promoter in the recombinase-dependent
viruses, thereby implementing intersecting promoter and recom-
binase-dependent specificity. Third, while generation of recom-
binase-dependent opsin mouse lines for simply crossing with
Cre driver lines is a viable approach (Madisen et al., 2010a,ng a combination of promoter or Cre-based approaches. Light delivery to the
s-activation.
wo wavelengths matched to the respective opsins expressed upstream.
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Table 3. Cre Driver Mouse Lines Successfully Employed for Biological Findings in Optogenetic Studies
Mouse Line Expression In Vector Used Use References
PV::Cre Cortical fast-spiking inhibitory
interneurons
AAV-DIO-ChR2(H134R)-EYFP
AAV-DIO-ChETA-EYFP
AAV-DIO-eNpHR2.0-EYFP
Cardin et al., 2009;
Sohal et al., 2009;
Gunaydin et al., 2010
D1-Cre, D2-Cre Striatal medium spiny neurons
of the direct and indirect pathway
AAV-DIO-ChR2(H134R)-EYFP Gong et al., 2007;
Kravitz et al., 2010;
Lobo et al., 2010
CaMKIIa-Cre Excitatory neurons in cortex,
hippocampus
AAV-DIO-ChR2(H134R)-mCherry Cardin et al., 2009
Six3-Cre Mostly cortical layer 4 neurons AAV-FLEX-ChR2(H134R)-mCherry Petreanu et al., 2009
ChAT-Cre Cholinergic neurons AAV-DIO-ChR2(H134R)-EYFP
AAV-DIO-eNpHR3.0-EYFP
Witten et al., 2010;
Chuhma et al., 2011
TH-Cre Dopaminergic neurons (VTA),
Noradrenergic neurons (LC)
AAV-DIO-ChR2(H134R)-EYFP
AAV-DIO-eNpHR2.0-EYFP
AAV-DIO-eNpHR3.0-EYFP
Tsai et al., 2009;
Carter et al., 2010
DAT-Cre Dopaminergic neurons AAV-DIO-ChR2(H134R)-mCherry Brown et al., 2010;
Stuber et al., 2010
ePet-Cre Serotonergic neurons (Raphe) AAV-DIO-ChR2(H134R)-mCherry Depuy et al., 2011
Gad2::Cre-ERT2 Cortical inhibitory neurons ROSA26::ChR2-EGFP
transgenic mouse
Ka¨tzel et al., 2011
Agrp-Cre
pomc-Cre
Hypothalamic Agrp neurons
Hypothalamic pomc neurons
AAV-FLEX-rev-ChR2:tdtomato Aponte et al., 2011
PKCd-GluCl-IRES-Cre Amygdala PKCd+ neurons AAV-DIO-ChR2(H134R)-EYFP Haubensak et al., 2010
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expression levels may be weaker than with high-copy-number
recombinase-dependent viruses, and more importantly the viral
approach provides a unique advantage of intersecting genetic
and anatomic specificity.
To illustrate this point, consider that for most Cre driver lines,
specificity exists only at particular points in space and time. For
example, consider a tyrosine hydroxylase (TH)::Cre line crossed
with a Cre-dependent opsin mouse line; even transient expres-
sion of Cre in any cell that contained an active TH promoter at
any developmental time point could serve to permanently acti-
vate opsin expression in that cell by irreversibly recombining
the Cre-dependent opsin locus. While this property could be
useful for developmental or cell-history information if properly
controlled, and when not desired this effect can be addressed
with inducible Cre driver lines (e.g., IRES-Cre-ERT2; Ka¨tzel
et al., 2011), potential leak in the baseline inducibility of such
systemsmust be considered, and amore fundamental confound
also exists. In this example, the tyrosine hydroxylase (TH)::Cre
drivers will express Cre not only in dopaminergic cells and fibers
from the VTA and substantia nigra, but also in widely projecting
noradrenergic cells from the solitary tract nucleus and locus co-
eruleus. This is a general problem; for example, in parvalbumin
(PV)::Cre lines or other GABAergic lines, known nonlocal projec-
tions will confound the interpretation of local targeted-neuron
function. In contrast, selective injection of a Cre-dependent virus
in one or another of these anatomical loci at a definedmoment in
time in a Cre-driver organism (Tsai et al., 2009; Carter et al.,
2010; Haubensak et al., 2010) provides additional specificity
and enhances the utility of the opsin driver lines (Figure 2A).
For example, in an elegant series of experiments, Anderson20 Neuron 71, July 14, 2011 ª2011 Elsevier Inc.and colleagues were able to show that PKCd+ GABAergic
neurons in the CeL nucleus of the amygdala provide feed-
forward inhibition onto CeM nucleus ‘‘output’’ neurons, using
ChR2 expressed by Cre-dependent virus in a PKCd+ mouse
driver line; due to the precision of the virus approach, PKCd+
specificity in the Cre driver line was only required in that specific
circuit at that specific phase of organismal life. Optogenetically
activated PKCd+ neurons were driven while simultaneously
recording from output (PAG-projecting) CeM neurons retro-
gradely labeled with a fluorescent tag, and it was observed
that blue light produced direct GABAergic inhibition of CeM
spiking (Haubensak et al., 2010).
Genetically guided optogenetic investigations now can
include multiple forms of transgenesis and optical control (e.g.,
Kravitz et al., 2010; Lobo et al., 2010; Higley and Sabatini,
2010). However, the concept of a ‘‘cell type’’ may not always
be definable genetically. While a simple form of the genetic
identity concept could encompass a wide swath of possible
cell types spanningmajor aspects of neurotransmitter/neuromo-
dulator function, receptor expression, biophysical properties
governed by ion channel expression, developmental origin,
and the like, it is also possible that cells could look the same
from the genetic standpoint but serve fundamentally different
functions by virtue of differential wiring. This important concept
happens to dovetail well with a unique and surprising strength
of optogenetics termed ‘‘projection targeting’’; this is the ability
to selectively drive or inhibit cells defined by their wiring or
projections.
Projection Targeting
Microbial opsin gene products, especially with assistance from
molecular engineering such as the addition of cellular trafficking
Neuron
Primermotifs (e.g., Gradinaru et al., 2008, 2010), may traffic down
dendrites (Lewis et al., 2009; Gradinaru et al., 2010; Greenberg
et al., 2011) or axons (Gradinaru et al., 2010; Lewis et al., 2011)
and create light-sensitive projections. This property, in the
setting of anatomical specificity provided by viruses, allows
transduction of cell bodies in one brain region and illumination
of axonal projections in another (Gradinaru et al., 2007, 2009;
Petreanu et al., 2007; Lee et al., 2010; Tye et al., 2011;
Figure 2C), thereby defining a cell population for excitation or
inhibition by virtue of its connectivity. The effects provided by
a channelrhodopsin when present in an axon terminal may act
via the combined influence of voltage-gated Na+ channels and
voltage-gated Ca2+ channels (perhaps along with, and under
certain conditions, the direct but small Ca2+ conductance of
channelrhodopsins; Zhang and Oertner, 2007), with resulting
release of neurotransmitters and activation of downstream
neurons. Stimulation of presynaptic terminals with optogenetic
tools has been reported to lead to a remarkably high probability
of release (pr) in hippocampal CA3-CA1 synapses, associated
with paired-pulse depression, in contrast with a lower pr and
paired-pulse facilitation resulting from electrical stimulation
(Zhang and Oertner, 2007). Several studies have taken advan-
tage of these properties to elucidate the synaptic output of
defined axonal projections into brain regions, both in the slice
preparation (Petreanu et al., 2007; Gradinaru et al., 2007; Zhang
and Oertner, 2007; Cruikshank et al., 2010; Stuber et al., 2010)
and in vivo (Gradinaru et al., 2009; Hull et al., 2009; Lee et al.,
2010; Tye et al., 2011). This approach could ultimately be
extended to the use of two excitatory opsins expressed in two
brain regions, the afferents of which converge onto a third region.
Optical stimulation with the appropriate wavelengths in principle
could then be used to combinatorially drive synaptic activity in
the two pathways (Figure 2F).
A major caveat of this approach is that ‘‘projection targeting’’
of a cell means only that a cell is being targeted by virtue of its
projection; while this alone is very useful, without further valida-
tion it may not be assumed that only a specific projection of a cell
is being excited or inhibited in isolation, due to the possibility of
antidromic propagation of evoked spikes, and even antidromic
spread of hyperpolarization. Where important for experimental
interpretation, such possibilities must be carefully considered
with control measurements (e.g., Tye et al., 2011). In some
settings, it may be found that it is an entire cell (defined by pos-
sessing the illuminated projection) that is being recruited, and in
many cases this will be precisely what is desired. In other cases,
it may be found that only the projection is being controlled with
little or no effect at the soma; again in other cases this will be
the desired effect. Regardless, where important this parameter
should be explored in the system under investigation, as the
net effect may depend upon axon caliber, myelination status,
length, and branching properties, as well as upon illumination
conditions and opsin gene properties (discussed in Tye et al.,
2011).
This approach provides a versatile promoter-independent
means to control cells, requiring only anatomical information,
and even with simple light guidance strategies this method can
be applied to projections as short as hundreds of micrometers
(Tye et al., 2011). A caveat of this approach is that all local photo-sensitive axons will be driven by light, even fibers of passage that
do not synapse in the illuminated region. Controls to define
a projection termination can be conducted by pharmacologically
inhibiting synaptic receptors in the target region, but even
more refined ‘‘projection termination targeting’’ strategies are
possible, involving labeling of cells for optogenetic control based
on formation of synapses in a defined anatomical location. For
example, a transsynaptic or transcellular tracer protein such as
wheat germ agglutinin (WGA) fused to Cre recombinase can be
expressed in cells of interest in the synaptic target location (Gra-
dinaru et al., 2010), while in the candidate projection-source
region a Cre-dependent opsin virus may be injected (Figure 2D).
In this configuration, with appropriate experimental conditions,
only neurons that form synaptic terminations in the target region
will receive Cre directly and express the opsin. A major caveat is
that this approach may not function in the same way in all
circuits, and the properties of the transcellular transport must
be validated in each experimental system, as anterograde and
retrograde trafficking are both theoretically possible (discussed
in Gradinaru et al., 2010), and in principle at longer timescales
multiple synapses could be traversed. One advantage of this
overall approach—if appropriate controls are conducted and
successful transcellular transport observed—is that light may
in this case be delivered at the cell body (a configuration that
can be especially robust), while retaining specificity of the
manipulation to those cells that make the desired projection
(Figure 2D).
A similar approach may be applied using axon terminal-
infecting or retrogradely transported viruses such as rabies or
herpes simplex virus (Callaway, 2008) or the canine adenovirus
(CAV; Hnasko et al., 2006), although some concern exists over
possible toxicity, especially when membrane proteins are ex-
pressed using these viral systems. Interestingly, some AAV sero-
types (generally better tolerated) are also modestly capable of
axon terminal infection or retrograde transport (Burger et al.,
2004; Towne et al., 2010). Recently, a modified retrograde
approach has been developed to map the entire synaptic
network converging onto a single cell, labeled with in vivo micro-
electroporation (Marshel et al., 2010), a technical advance that
could well dovetail with optogenetic control.
Transgenic Animal Targeting
As described above, the limitations imposed by packaging
capacity in viral systems can be overcome using single-compo-
nent optogenetic tools (for example, by using recombinase-
dependent opsin-expressing viruses and/or by leveraging
relevant anatomy for projection targeting). Beyond the benefits
of speed, flexibility, spatiotemporal targeting precision, and
high gene copy-number, virus injection into recombinase
driver lines also can uncouple promoter specificity from expres-
sion strength, since opsin expression is related to the copy
number of the virus with its strong nonspecific promoter, and
resulting transcription can exceed endogenous transcription
from tissue-specific promoters. However, another major class
of strategy, generation of mouse transgenic lines directly ex-
pressing opsin genes under local promoter-enhancer regions
(i.e., not in a recombinase-dependent fashion), provides a
distinctly useful means of achieving cell-type-specific opsin
expression. While transgenic mouse lines require effort, time,Neuron 71, July 14, 2011 ª2011 Elsevier Inc. 21
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convenience and reliability of homogeneous opsin-expressing
animals provides major experimental leverage.
The Thy1::ChR2-EYFP mouse lines (Arenkiel et al., 2007;
Wang et al., 2007) express ChR2 under control of the Thy1
promoter. While as discussed above promoters do not suffice
to completely define cell types and the complement of labeled
cells must be considered in each case, Thy1-driven expression
is largely restricted to projection neurons, enabling several
studies in which optogenetics was applied to study cortical
connectivity (Wang et al., 2007), transmission from the olfactory
bulb to cortex (Arenkiel et al., 2007), aspects of ganglion cell
function in visual impairment (Thyagarajan et al., 2010), cortical
information processing (Sohal et al., 2009), and parkinsonian
circuitry (Gradinaru et al., 2009). For example, in the latter study
it was found that therapeutic deep brain stimulation (DBS) in the
subthalamic nucleus (STN) arising from a point source (e.g.,
electrode or fiber) is by far most effective when the direct target
is afferent axons within the structure (these axons then efficiently
modulate both downstream and upstream neurons—and indeed
potently reduce local STN spiking); much weaker effects were
seen with direct modulation of local cell bodies in the STN by
a point source of control, suggesting electrical DBS might be
best designed to target axonal tracts rather than gray matter.
A defined local cell type was targeted in a pioneering study by
Kiehn and colleagues (Ha¨gglund et al., 2010), in which VGLUT2
cells in the spinal cord expressed a channelrhodopsin. Optically
controlled activation of specific groups of excitatory neurons in
either the mouse spinal cord or hindbrain was found to evoke
stereotypical locomotion, illustrating the principle of precise
optogenetic control of transgenically defined neurons in the
context of a well-defined, complex, and behaviorally significant
behavioral output (Ha¨gglund et al., 2010). This approach is
generalizable as well, and many additional transgenic opsin-
expressing mouse lines have now been described (Zhao et al.,
2010; Ren et al., 2011) as well as conditional opsin lines dis-
cussed in more detail below (Ka¨tzel et al., 2011; Chuhma et al.,
2011); for example, the latter study utilized a tTA/tetO strategy
and crossed two mouse lines to achieve specific expression of
a channelrhodopsin in striatal medium spiny neurons (Chuhma
et al., 2011).
Spatiotemporal Targeting
Cells may also be targeted by virtue of their birthdate or prolifer-
ation status, location at a moment in time, and other versions of
what might be called ‘‘spatiotemporal’’ targeting; this approach
has reached its most advanced state in the course of targeting
specific neocortical layers (Petreanu et al., 2007, 2009; Gradi-
naru et al., 2007; Adesnik and Scanziani, 2010).
A long-sought goal of neuroscience has been to tease apart
the role of specific layers, and of layer-specific neurons, in
cortical microcircuit processing, brain-wide network dynamics,
and animal behavior. In utero electroporation (IUE) may be
employed to target opsins to distinct layers of the cortex, capital-
izing on the sequential layer-by-layer ontogeny of neocortex in
mammals, by incorporating the DNA into neurons generated
during a specific embryonic stage (Petreanu et al., 2007, 2009;
Huber et al., 2008; Adesnik and Scanziani, 2010). Beyond this
special targeting capability, an additional unique advantage of22 Neuron 71, July 14, 2011 ª2011 Elsevier Inc.IUE is that opsins are expressed from before the time of litter
birth (allowing electrophysiological experiments at a younger
stage than with viral expression).
Optogenetic tools have been well tolerated when electropo-
rated into mouse embryos in naked plasmid form. In principle,
cells may also be targeted for optogenetic control by (1) active
proliferation status at a particular moment in time, using cell-
cycle-dependent Moloney-type retroviruses (Toni et al., 2008);
(2) location at a particular moment in time (e.g., via migration
through a particular anatomical location during development;
and (3) othermethods including ex vivo sorting followed by trans-
duction and transplantation. In general, the range of genetic
techniques for delivering opsin genes into the brain has become
broad and versatile and leverages the intrinsic tractability of the
single-component microbial opsin tools.
Associated Enabling Technologies for Optogenetics
in Neuroscience: Light Delivery
Once the desired opsins have been targeted to neurons of
interest, the next experimental consideration is light delivery.
Requirements vary widely across experimental paradigms. For
instance, amultiple-opsin study of fast oscillations in a brain slice
preparation will require a different light delivery approach than
a study of the effects of prolonged stimulation of a deep brain
nucleus in a behaving animal. Next we review strategies for
meeting the light requirements for particular experimental
applications via the spatial, temporal, and spectral control of
illumination.
Light Requirements for Activation at the Molecular
and Cellular Level
The photocurrent in a neuron resulting from a pulse of light will
depend upon many factors, including the properties of the opsin
being expressed, the wavelength, intensity and duration of
the incident light, and even recent illumination history (if fewer
channelrhodopsin molecules begin in or have returned to the
dark-adapted state, the initial transient response to a light pulse
will be smaller, though the steady-state photocurrent may remain
the same; Boyden et al., 2005; Rickgauer and Tank, 2009). In all
cases, however, the rate of absorption of photons of a given
wavelength is proportional to the local photon flux; that is, the
number of photons incident per unit time per unit area. When
designing a light delivery system to activate rhodopsins, it is
therefore chiefly this parameter that we wish to measure and
control.
Given the ease of measuring total light power (in Watts) using
commercially available light power meters, it is more convenient
to measure and report ‘‘light power density’’ (typically measured
in mW/mm2), rather than photon flux. Light power density is
simply the photon flux multiplied by the energy of the individual
photon, which is inversely proportional to wavelength. For
wild-type ChR2 at typical expression levels and illuminated
with 473 nm light, light power densities of 1–5 mW/mm2 were
initially found to be sufficient to elicit action potentials (Boyden
et al., 2005). Light requirements vary among different optoge-
netic tools, and one must consider the specific properties of
the opsin-retinal complex when designing the experiment. For
example, optogenetic inhibition may require continuous light
for as long as inhibition is desired, whereas bistable optogenetic
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Figure 3. Light Propagation in Brain Tissue
for In Vivo Optogenetics
(A) Schematic showing that the maximum activa-
tion depth is the depth at which the light power
density falls below the activation threshold, PDmin.
(B) Measured percent transmission of light power
at 473 nm, 561 nm, 594 nm, and 635 nm light from
a fiberoptic (200 mm, NA = 0.37) shown as a func-
tion of distance from the fiber tip in brain tissue.
Solid lines represent fits to the measured data
(Aravanis et al., 2007).
(C) Predicted fraction of initial light power density
as a function of depth in brain tissue for the same
fiber; includes effects of absorption, scattering,
and geometric light spread.
(D and E) Lateral light spread as a function of
sample thickness. Saline solution (top) or rat gray
matter (bottom) was illuminated by either blue
(473 nm; left) or yellow (594 nm; right) light deliv-
ered through a 200 mm optical fiber (NA = 0.37).
Images are sections through a 3D map of light
intensity along the axis of an illuminating fiber.
Contour maps of the image data show iso-inten-
sity lines at 50%, 10%, 5%, and 1% of maximum.
Note conical spread of light in saline due to fiber
properties, and more symmetrical light propaga-
tion shape in brain tissue.
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Primercontrol (Berndt et al., 2009) only requires brief, widely spaced
light pulses, typically at much lower power (<0.01 mW/mm2).
We recommend that the light power density, rather than total
power, be reported in optogenetic studies. When illuminating
cultured cells with light coupled into a microscope’s beam path,
calculating light power density can be as simple as dividing the
total emitted light power by the area of the illuminated spot.
However, when shaped beams of light are directed into larger
volumes of tissue, such as with optical fiber illumination of
the intactbrain, estimating lightpowerdensityat the targeted loca-
tion requiresaccounting for attenuation introducedbybeamdiver-
genceand theoptical propertiesof the illuminated tissue (Aravanis
et al., 2007 and see below). Such calculations also help estimate
the volume of tissue recruited by the light stimulus in vivo and
are critical for the design and interpretation of experiments.
Optical Properties of Brain Tissue
For a given opsin gene, functional expression levels and the light
power density reaching the expressing cells will together deter-
mine the efficacy of light-based control (Figure 3A). To estimate
this density of light reaching the targeted cells onemust consider
the propagation of light in tissue. Light propagation in biological
tissue can be modeled as a combination of absorption and
scattering, with scattering playing an especially important role
in mature myelinated brain tissue (Vo-Dinh, 2003). The transmis-
sion properties of light through the brain also depend strongly on
wavelength, with longer-wavelength light scattering less and
therefore penetrating more deeply (Figure 3).NeuroWe have taken several complementary
approaches to measuring and estimating
the depth of light propagation under
typical experimental conditions, specifi-
cally for the illumination of deep brain
structures using thin optical fibers. In
one approach (Aravanis et al., 2007), anoptical fiber emitting a known light power was lowered into
a block of unfixed brain tissue, and light power was measured
on the underside of the block, giving a transmission fraction for
the tissue sample (nontransmitted light was either absorbed by
or reflected out of the sample). This measurement was repeated
for a range of tissue thicknesses by stepping the fiber through
the block. These data were fit with standard equations for the
propagation of light in diffuse scattering media (Kubelka-Munk
model; Vo-Dinh, 2003), in order to estimate parameters that
could be used to predict depth of transmitted light power in other
experimental configurations.
To estimate the light power density at a given distance from
the fiber tip, the beam was modeled as spreading conically
within the tissue, with an angle determined by the optical prop-
erties of the fiber. This model, while involving a number of unre-
alistic assumptions including that the sample is a homogeneous,
ideal diffuser illuminated from one side with diffuse light, and
that reflection and absorption are constant over the thickness
of the sample, nevertheless allowed a good fit to measured
data (Figures 3B and 3C; Aravanis et al., 2007) when used to esti-
mate light power density at progressively deeper sites. Next, to
directly observe the lateral spatial extent of the illuminated region
at various distances from the fiber, we repeated the experiments
above with the block of brain tissue placed on a thin diffusing
layer revealing the two-dimensional pattern of illumination at
the bottom of the block; this screen was imaged from below
as the fiber was lowered through either brain tissue, or salinen 71, July 14, 2011 ª2011 Elsevier Inc. 23
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three-dimensional volume (Figures 3D and 3E). The light power
density profiles directly below the fiber were in general agree-
ment with the attenuation predicted by the simple conical model,
for distances corresponding to relative light power densities
down to 5% of the initial value. At greater distances, the higher
number of scattering events results in a higher degree of lateral
spread. A useful rule of thumb based on these direct measure-
ments (Figure 3E) is that the full (edge to edge) width of lateral
light spread, arising from an optical fiber in gray matter, is quan-
titatively similar to the full depth (fiber tip to edge) of forward light
spread at a given light level.
Thesedirectmeasurements provide the basis for a quantitative
estimation of the volume of tissue recruited during optogenetic
experiments, have been validated by light measurements and
electrophysiology at known distances from the illumination
source (Aravanis et al., 2007; Adamantidis et al., 2007; Gradinaru
et al., 2009; Cardin et al., 2009; Tye et al., 2011), and are gener-
ally consistent with immunohistochemical staining for molecular
markers of elevated activity such as c-fos (Gradinaru et al.,
2009). Complementing thesemeasurements, estimates of trans-
mission of light can be simulated with Monte-Carlo methods
(e.g., Bernstein et al., 2008), and as the geometry and chemical
composition of brain tissue are complex neither the simple
models nor the Monte Carlo simulations can be relied upon
without validation using direct measurements. Transmission
measurements and estimated light power densities for blue
(473 nm) and green (561 nm) light emitted from a fiberoptic
have been previously reported (Aravanis et al., 2007; Adamanti-
dis et al., 2007), but the advent of the new red-shifted optoge-
netic tools described above requires consideration of additional
wavelengths of light; here, we report these values for 473 nm,
561 nm, 594 nm, and 635 nm light in brain tissue (Figures 3B
and 3C). A simple calculator that estimates light power density
as a function of depth in tissue, using the data reported here
and allowing user input on wavelength, light power, and fiber
type, is available online at www.optogenetics.org/calc. This
depth estimation, when combinedwith the empirical observation
that the full (edge to edge) width of lateral light spread is quanti-
tatively similar to the depth of forward light spread from the fiber
tip for a given contour, allows rapid estimation of illumination
profiles for in vivo work. Spatial light targeting can bemultiplexed
with the opsin targeting strategies described above to further
restrict which components of the neural circuit are modulated.
Controls for Nonspecific Effects of Opsin Expression
and Light Delivery
The expression of exogenous opsins in tissue and the delivery of
the light needed to activate them may also result in unintended
effects, such as toxicity or tissue heating. Viral infection and
the expression of exogenous proteins at high levels could alter
cellular capacitance (Zimmermann et al., 2008), alter cellular
physiology, or even lead to toxicity; we and others have found
that the CMV, CAG, and rabies-based promoters may express
opsins at very high levels that can cause protein accumulations
or structural abnormalities in the targeted neurons over time.
However, very long-term expression of any membrane (or other
exogenous) protein with even more moderate-strength
promoters can cause toxicity, and we have found that expres-24 Neuron 71, July 14, 2011 ª2011 Elsevier Inc.sion strength and time of expression interact in giving rise to
this phenomenon.When employed, fusion proteins could appear
to mimic such an effect, but some fluorescent proteins such
as mCherry to which opsins are commonly fused themselves
can clump and accumulate, while not necessarily impairing
opsin function or cell health (e.g., Adamantidis et al., 2007).
Regardless, it is important to track membrane resistance and
resting potential; modest trends of effects on these membrane
properties are occasionally seen with high level opsin expres-
sion. Especially when such an effect is observed, it is important
to carry out no-light controls in opsin-expressing tissue or
animals.
Indeed, in theory not only intrinsic neuronal properties (such as
input resistance, membrane capacitance, and excitability) could
be altered by toxicity linked to long-term or very high-level
membrane protein overexpression, but even functional output
and effective synaptic connectivity could be altered. A no-light
control condition in which the tissue is virally transduced, but
no light is delivered, can address these effects and is especially
valuable when the light delivery paradigm does not involve
switching on-and-off and therefore within-animal controls are
less feasible (Tsai et al., 2009). For invertebrates such as
C. elegans and D. melanogaster, where retinal is not present
but may be easily supplied in food or substrate, another type
of control is possible, the retinal-negative condition (Zhang
et al., 2007).
Light used to activate opsins may also produce nonspecific
effects. Light leaking from the delivery apparatus, or scattered
through brain tissue may reach light-sensing organs such as
the retina, directly affecting neural activity, or leading to changes
in an animal’s behavior. Light absorbed by tissue could also
result in photodamage or local temperature increases. It is there-
fore critical that parallel no-opsin control experiments using
identical illumination conditions are included in optogenetic
experiments (e.g., Adamantidis et al., 2007; Tsai et al., 2009;
Lee et al., 2010).
The issue of tissue heating by light deserves special consider-
ation, since even temperature changes too small to cause
detectable tissue damage can lead to significant physiological
(Moser et al., 1993) and behavioral (Long and Fee, 2008) effects.
Consider pulsed laser light delivered to a deep brain region by
a thin optical fiber. Light is emitted in a conical pattern, then
scattered and absorbed as it passes through optically inhomo-
geneous brain tissue. Heat will be generated wherever light is
absorbed, in proportion to the light intensity at each point, giving
rise to a heat source that is distributed throughout the tissue. The
temperature gradient resulting from this heating will be counter-
acted over time by conduction of heat, bymass transfer (e.g., the
perfusion of the region by blood), and possibly also by changes
in metabolic heating as a result of stimulation or inhibition.
Notably, both scattering and absorbance vary with light wave-
length, with absorbance 10 times higher at 475 nm than
600 nm (Yaroslavsky et al., 2002). Therefore, even under condi-
tions of equivalent total light power delivery to the brain through
the same optical fiber, the spatial structure of the resulting heat
source can be markedly different for different wavelengths.
As an exercise it may be useful to estimate an upper bound
for temperature changes resulting at a targeted region under
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expected temperature changes should always be considered
but need not be in a range that might be expected to influence
neurophysiology. For an optical fiber (200 mm, NA = 0.37) placed
0.5 mm above a targeted region, emitting 5 mW of blue (473 nm)
light, the predicted (see above) local irradiance at the target is
4.9 mW/mm2 (Aravanis et al., 2007). Multiplying this by the
coefficient of absorption for brain tissue at 473 nm of approxi-
mately 0.1 mm1 (Yaroslavsky et al., 2002), gives a local light
power deposition rate of 0.49 mW/mm3. If light is delivered to
the brain as 5 ms pulses at 20 Hz for 30 s (the equivalent of 3 s
of constant illumination), total energy deposition would be
0.49 3 3 = 1.47 mJ/mm3. If we conservatively assume that this
power were delivered as an impulse (i.e., ignoring the mitigating
effects over time of conduction and blood flow), then given
a specific heat of brain of 3650 mJ 3 g1 3 C1 and a brain
density of 0.00104 g/mm3 (Elwassif et al., 2006), we would
expect a local change in temperature of 1.47 / (0.00104 3
3650) = 0.38C. Larger temperature excursions would be
expected at nontargeted regions closer to the fiber tip, where
irradiances are much higher. However, at such locations, the
assumption of zero conduction used in the above calculation is
less reasonable since the local temperature gradients would
also be much steeper (due to both the exponential falloff of irra-
diance with distance and the proximity of nonilluminated tissue).
Moreover, the light is certainly not condensed into a single
impulse in optogenetic experiments, where pulsed light or
delivery over time is the norm.
Deep brain temperatures in rodents are known to vary natu-
rally over a range of several degrees C as a result of circadian
rhythm, exercise, and environmental temperature (Moser et al.,
1993; DeBow and Colbourne, 2003). While the expected heating
from light under typical conditions is much less than this normal
range, even small systematic differences between light on and
off conditions could contribute to any observed behavioral or
physiological effects; moreover, if investigators use higher light
powers or contribute to additional heat sources with local
LEDs instead of remote diodes, heating effects will become rele-
vant. We therefore re-emphasize the need for opsin-negative
controls especially in cases where continuous light is delivered,
and suggest the importance of more sophisticated modeling of
brain heating (such as have been developed to study thermal
effects of electrical stimulation (Elwassif et al., 2006) in future
work.
Light Sources
Depending on the application, some optogenetic experiments
may require a light source with stringent requirements to emit
a specific distribution of wavelengths with fast temporal modula-
tion, at high power, and with a particular spatial pattern. Since
microbial opsin-derived tools can be deactivated by light of
wavelengths near the activation wavelength (Berndt et al.,
2009), light sources with sharp spectral tuning are generally
preferred over broadband light sources; sharp tuning is also crit-
ical when attempting to selectively activate a single tool in a
multiple-opsin experiment. Moreover, some experiments may
require precise temporal control of light power (e.g., dynamic
clamp experiments; Sohal et al., 2009), while others may require
especially stable continuous illumination over long periods (e.g.,during a long-lasting inhibition protocol (Carter et al., 2010). And
finally, achieving sufficient light output from miniaturized optical
components represents another significant challenge. Here we
will discuss these crucial issues in the context of light source
hardware and review the benefits and limitations of various
technologies currently in use.
Lasers
Lasers are an appealing option for many types of optogenetic
experimentation, with a very narrow spectral linewidth (typically
< 1 nm), which can be matched closely to the peak activation
wavelength of the optogenetic tool of interest; moreover, many
lasers can be directly modulated at kilohertz frequencies. Laser
beams have a very low divergence, and so can be readily steered
through various optical elements on an optical table, such as
electronic shutters, beam splitters, power meters, and dichroic
mirrors for combining multiple laser lines (Figure 4A). The narrow
width and low divergence of laser beams are especially impor-
tant when attempting to couple light into optical fibers, which
require light to be focused to a small spot size (50–400 mm) at
a shallow angle in order to be effectively coupled.
For integration into physiological experiments, we have found
that that diode lasers and diode-pumped solid-state (DPSS)
lasers are the most appropriate (Aravanis et al., 2007; Adaman-
tidis et al., 2007). Lab-quality models are offered by several
vendors (Cobolt, Omicron, Newport, Crystalaser, OEM Laser
Systems) in a number of useful wavelengths across the opsin
action spectrum with sufficient continuous-wave (CW) output
power; these include appropriate focusing optics and mounting
hardware and are compact, portable, and robust for daily lab
use. We have found that direct diode lasers tend to be more
reliably modulated at high speeds than DPSS lasers at similar
wavelengths. Lasers with a power output of 100 mW are typi-
cally used, driven with a power supply that allows for analog
modulation of output power. This level is sufficient to generate
high light power densities out of small optical fibers even after
coupling and transmission losses, after splitting into multiple
fibers, and after some degradation of output power with use.
Different wavelength outputs from DPSS lasers are achieved
by using different combinations of pump diodes and solid-state
gain media. Due to differences in the complexity, efficiency, and
tolerances of these devices, and in the control electronics they
require, DPSS lasers of the same power but different wavelength
can vary more than 10-fold in price and have very different
performance characteristics, especially with respect to temporal
modulation. For instance, 473 nm and 532 nm DPSS lasers can
reliably generate 1 ms pulses (though for pulses < 100 ms in
duration, the average power during a pulse may be significantly
less than the steady-state output at the same command voltage;
Figure 4B). On the other hand, 593.5 nm (yellow) DPSS lasers
cannot be reliably modulated even at the second timescale, so
we employ instead a high-speed shutter in the beam path
(Uniblitz, Stanford Research Systems, Thorlabs; Figure 4A).
High-speed beam shutters can be acoustically noisy (though
low-vibration shutters are manufactured by Stanford Research
Systems), and so experiments must be designed such that this
auditory stimulus time-locked to laser illumination does not
become confounding for intact animal preparations (even in
anesthetized preparations).Neuron 71, July 14, 2011 ª2011 Elsevier Inc. 25
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Figure 4. Two-Laser Setup for Optogenetic Stimulation
(A) Two solid-state lasers are coupled into a single fiberoptic cable for two-
color modulation. A fast laser shutter is used to control the output of the yellow
(593.5 nm) laser, due to its slow analog modulation. Beam pick-offs allow for
online monitoring of laser output by photodetectors. An optical fiber
commutator enables animals to freely move in the behavior apparatus without
fiber twisting or breakage. A fiberoptic cable connects from the commutator to
a fiberoptic implant consisting of a metal ferrule with a permanently attached
fiberoptic cable that extends into the target region.
(B) Light power traces from three laser configurations generating 10 ms light
pulses at 10 Hz for 4 s. Top: A blue (473 nm) DPSS laser (e.g., OEM lasers)
directly modulated using the laser’s TTL modulation mode. The upward power
drift across the pulse train was repeatable. Middle: The same laser, with same
command power, but in continuous operation, with modulation provided by
a mechanical shutter (LS-2, Uniblitz) in the laser path. Bottom: A 488 nm direct
diode laser (Phoxx, Omicron-Laserage).
(C) Expanded view of the first and last pulses from (B). Note the ramping up of
power and the reduced mean power output of the DPSS laser in response to
a short pulse (top) as compared to the same laser’s steady state output
(middle), and the 1 ms delay introduced by the shutter (middle).
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protocols using a high-speed photodetector (many commercial
power meters have an analog output that allows the raw light
power signal to be observed on an oscilloscope). Online26 Neuron 71, July 14, 2011 ª2011 Elsevier Inc.measurement of light power during experiments may also be
achieved by using a beam pickoff that directs a small fraction
of the modulated laser power to a photodetector continuously
during an experiment (Figure 4A).
LEDs
Light-emitting diodes (LEDs) are another attractive light source
for certain optogenetic applications. LEDs have the required
narrow spectral tuning (spectral linewidth at half maximum
typically in the 10 s of nm), are readily modulated at the frequen-
cies required, are simple and inexpensive, and do not require
complex control electronics; however, when used near tissue,
substantial heat is generated and caution is indicated for
in vivo use. Like lasers, only a limited number of colors are
available that emit adequate power, though increasing the power
output and spectral diversity of LEDs is an active area of
research. In vitro, LEDs can serve as the light source for optoge-
netic experiments (Ishizuka et al., 2006; Gradinaru et al., 2007;
Petreanu et al., 2007; Campagnola et al., 2008; Adesnik and
Scanziani, 2010; Grossman et al., 2010; Wen et al., 2010), and
LED arrays are available that permit focal stimulation of single
cells, or even single neurites (Grossman et al., 2010). For
in vivo applications, LEDs can be used to fill an optical fiber
which is tethered to a behaving animal, but such applications
are limited by the highly divergent beam pattern from LEDs
with coupling efficiencies of 1%; still, with high-power LEDs,
this fraction of total power is sufficient to attain the required
power density output (Gradinaru et al., 2007; Petreanu et al.,
2007). Possible uses of LEDs include both direct implantation
of small LEDs in or on tissue (with heating concerns requiring
careful control as noted above), or permanently mounted to
optical fiber waveguides carried on the subject (Iwai et al., 2011).
Incandescent Sources
Traditional broadband incandescent microscopy light sources,
such as arc lamp-based epifluorescence illuminators, can be
used in optogenetic experiments with appropriate narrowband
spectral filters and the introduction of a shutter to the illumination
beam path. Dedicated light sources with built-in high-speed
shutters and filter selection are also available (e.g., the Sutter
Instruments DG-4; Boyden et al., 2005) and offer pulse durations
of as little as 1 ms with pulse repetition rates of up to 500 Hz.
Unlike some lasers and LEDs, which offer graded modulation
of intensity, shutter-based systems are limited to on/off gating
of light pulses; neutral density filters can be used to produce
stepped illumination. One significant advantage of the use of
filtered broadband light over LEDs or lasers is the ability to select
arbitrary illumination wavelengths and spectral linewidth using
bandpass filters. Even more flexible are monochromators, which
output commanded wavelengths via positioning of a diffraction
grating.
Light Delivery: Surface Targets
In light-accessible experimental preparations such as cultured
neurons, brain slices, cortical surface, or nematodes, light is
typically delivered through a microscope illumination path,
passing through the objective and illuminating a spot within the
field of view. Apertures in the illumination path can be used to
restrict this spot to a smaller portion of the field. In order to
measure the light power density achieved by a given setup,
a power meter can be placed below the objective; the total
Figure 5. Implanted Fiberoptic Lightguide (IFL)
The lightguide is composed of a fiberoptic cable terminated by a metal ferrule
(1). The optic fiber can be cleaved to length based on stereotactic coordinates
(2) and light can then be delivered by attaching a matched fiber-ferrule pair
connected to the output of the laser apparatus (3). Coupling of the fibers leads
to light propagation through the implant (4).
Neuron
Primerpower is measured and divided by the area of the illumination
spot (Aravanis et al., 2007). For experiments requiring illumina-
tion at multiple sites, or at sites away from the imaged area, an
optical fiber-coupled light source (see below) can be mounted
on a micromanipulator and used to illuminate the tissue, with
light power density similarly calculated from total power and
spot size. Laser beams can be coupled into the microscope light
path and optically expanded to fill the field of view, and moving
optical elements—such as galvanometer-driven mirrors (Rick-
gauer and Tank, 2009; Losonczy et al., 2010), digital micromir-
rors (Farah et al., 2007; Arrenberg et al., 2010), or diffractive
optical elements (Watson et al., 2009)—can be combined with
microscope optics to deliver patterns of light to areas within
the imaging field.
Indeed, spatiotemporal light patterning is a field of increasing
relevance to many aspects of optogenetics (Shoham, 2010).
Various methods of spatial and temporal beam shaping have
been explored for delivering complex two- or three-dimensional
patterns of light for single-photon (Farah et al., 2007) or two-
photon control of microbial opsin-derived tools (Rickgauer and
Tank, 2009; Andrasfalvy et al., 2010; Papagiakoumou et al.,
2010). It remains to be seenwhichwill be themost useful or prac-
tical method for controlling multiple cells in versatile and rapid
fashion within intact tissue, but already individual cells can be
controlled independently within living brain slices (Papagiakou-
mou et al., 2010) and freely moving worms (Leifer et al., 2011;
Stirman et al., 2011), opening up immense opportunities for
systems neuroscience.
Light Delivery: Deep Targets
Delivering light to in vivo preparations presents several distinct
challenges compared with in vitro preparations. Light may
need to be targeted to deep brain structures while minimizing
damage to surrounding tissue, and in the case of behaving
animals without significantly disrupting the behavior under
study. To satisfy these requirements, we developed the opticalneural interface discussed above for use in vivo that employs
a thin optical fiber to carry light from a source (typically a laser)
directly to the targeted structure (Adamantidis et al., 2007; Ara-
vanis et al., 2007). While above we discussed the propagation
of light after emerging from the fiber, here we address the fibers
themselves.
Fiberoptics are thin, flexible cables made of transparent
material that act as waveguides for light. The dimensions and
optical properties of a particular fiber will interact with other
elements in the light delivery system to affect the geometry
and intensity profile of the light beam delivered to the brain. In
conjunction with an understanding of the optical properties of
brain tissue addressed above, such variation can be exploited
in the targeting of light to particular regions (Adamantidis
et al., 2007; Aravanis et al., 2007). The light-carrying fiber either
can be inserted directly into the brain using a stereotaxic appa-
ratus (for anesthetized preparations) or can be inserted into a
cannula previously implanted stereotactically. Alternatively, a
short length of optical fiber with one end located at the targeted
brain region, and the other end terminated by a miniature
fiberoptic connector (Doric Lenses, Quebec, Canada), can be
permanently implanted and attached to the skull. This last
method (implanted fiberoptic lightguide or IFL; Figure 5) is
preferred for chronic experiments for a number of reasons; the
bare fiber causes less damage than the larger cannula, the brain
is completely closed to the outside environment, and mating the
connector is easier and potentially less disruptive than inserting
a fiber into a cannula.
The most common type of fiber, called step-index, consists of
a light-carrying ‘‘core’’ material (often silica glass) surrounded by
a thin ‘‘cladding’’ layer of material with a slightly higher refractive
index (often a hard transparent polymer). For light delivery, fiber
with a core diameter from the 10 s to 100 s ofmicrons and a clad-
ding thickness around 10 microns is typically chosen, with larger
core diameters providing for easier and more efficient coupling
of light into the fiber and a larger emitting area within the brain.
Fibers of these dimensions support many (typically thousands)
of discrete light propagation modes, and are therefore referred
to as ‘‘multimode’’ fiber. The core and cladding may be sur-
rounded by a protective ‘‘jacket’’ or ‘‘buffer’’ layer, which does
not contribute to light transmission and is stripped from the fiber
before insertion into the brain (Aravanis et al., 2007; Zhang et al.,
2010). The interface between the core and cladding reflects light
traveling through the core at angles close to the longitudinal axis
of the fiber (a phenomenon called ‘‘total internal reflection’’), with
the difference in refractive indexes between the core and clad-
ding determining the maximum angle of rays that can propagate
through the fiber. This relationship is captured by the fiber’s
numerical aperture (NA), which also determines the maximum
acceptance angle for incoming light and the maximum exit angle
for the output light beam. Fibers with an NA from 0.1 to 0.5 are
readily available, giving exit cone angles into brain tissue from
8 to 42 degrees. Since the attenuation with distance from the
fiber tip depends partly on the geometric spread of light, fiber
NA contributes to the shape of the tissue activated by a given
total emitted light power.
Laser light can be efficiently coupled into the fiber with an
optical part that focuses the incoming beam onto the end ofNeuron 71, July 14, 2011 ª2011 Elsevier Inc. 27
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adjust using small screws are available, but we prefer to rigidly
attach the laser and coupler to an optical breadboard, and align
the beam using 2 adjustable steering mirrors (Figure 4), which
affords faster and more precise alignment. Moreover, this
arrangement allows for easy access to the beam path for intro-
ducing optical elements such as shutters, beam blocks, filters,
beam pick-offs, and power meters. Combining beams from
multiple lasers into a single fiber is also easily achieved by
the use of a dichroic mirror with the appropriate wavelength
cutoff.
Associated enabling technologies for optogenetics
in neuroscience: readouts
Optogenetic control has been shown to be compatible with
diverse behavioral readouts in organisms ranging from worms
and flies to fish and mammals, particularly since the fiberoptic
neural interfaces (Adamantidis et al., 2007; Aravanis et al.,
2007) are lightweight and flexible enough to allow complex
behaviors to be easily carried out in freely moving mammals.
One potential challenge to this approach could be a restriction
in movement arising from use of a fiber. Nevertheless, analogous
issues have been addressed and solved for electrical connec-
tors; in the case of optical hardware, optical commutators allow
tracks and arenas to be explored by fiberoptic-coupled
mammals exhibiting complex behaviors ranging from rapid
circling behavior to place preference and elevated plus maze
(Gradinaru et al., 2009; Witten et al., 2010; Tye et al., 2011).
Moreover, the latest generation of more light-sensitive and bista-
ble optogenetic tools may enable not only LED-based electrical
wire control during behavior, but also free behavior in the
complete absence of tethered optical devices (Berndt et al.,
2009; Yizhar et al., 2011a). Therefore, as behavioral measures
in the setting of optogenetics are relatively straightforward (Na-
gel et al., 2005; Adamantidis et al., 2007; Huber et al., 2008; Airan
et al., 2009; Tsai et al., 2009; Carter et al., 2009; Johansen et al.,
2010; Lobo et al., 2010; Witten et al., 2010; Tye et al., 2011) and
can be mapped onto the wide range of validated animal behav-
ioral measures present in the literature, here we do not focus on
behavioral measures, instead taking note of circuit-level read-
outs (electrical, optical, and magnetic resonance).
Electrical Readouts
A key advantage of optogenetic stimulation is that true simulta-
neous electrical recordings can be carried out. Such simulta-
neous input/output processing is not typically possible with
integrated electrical stimulation and electrical recording, due
to artifacts associated with electrical stimulation that have
stymied both basic systems neuroscience investigations and
our understanding of therapeutic brain stimulation modalities
such as DBS. Extracellular unit recordings are easily integrated
with light stimulation (Gradinaru et al., 2007, 2009), but local
field potential recordings with metal electrodes can be
confounded with electrical artifacts likely resulting from the
direct effects of light and temperature on the recording elec-
trode (Ayling et al., 2009; Cardin et al., 2010). Several simple
steps can be taken to assure that LFPs reflect neural activity,
including minimization of exposed metal area, use of glass elec-
trodes wherein the conducting wire can be placed further away28 Neuron 71, July 14, 2011 ª2011 Elsevier Inc.from the site of recording, and use of nichrome microwires
rather than tungsten microelectrodes. Control recordings
should be performed in brain regions that contain no opsin-ex-
pressing cells, with light at the same wavelength and power
density as those used in the experimental recordings within
the opsin-expressing region.
When light delivery and electrical recording are integrated into
a single device (Gradinaru et al., 2007), the resulting tool is
referred to as an ‘‘optrode’’ (Gradinaru et al., 2007, 2009; Zhang
et al., 2010). These have ranged from fusion of optical fibers with
metallic electrodes (Gradinaru et al., 2007, 2009), to coaxial inte-
gratedmultielectrode devices (Zhang et al., 2009a, 2009b; Royer
et al., 2010), to silicon probes for multi-site recording in awake,
behaving animals (Royer et al., 2010). An issue with all of these
extracellular methods is that there is no guarantee that recorded
spikes are arising from photosensitive cells, rather than from
indirectly recruited cells. Normally this is not a concern, and
optrode recordings still provide extremely useful feedback on
the activity in the local circuit during control that could never
be obtained with electrical stimulation. However, care must be
taken not to overinterpret (for example) latencies to spiking,
which can be highly variable in vivo due to differences in illumina-
tion intensity, as predictive of whether a unit is directly or indi-
rectly driven by light. Latencies as long as 10–12 ms or greater
are certainly possible for directly driven cells, while conversely
latencies as short as 3–4 ms should be possible even for indi-
rectly driven (nonphotosensitive) cells.
Optical Readouts
The concept of all-optical interrogation of neural circuits (Dei-
sseroth et al., 2006; Scanziani and Ha¨usser, 2009) is appealing
since spatial distribution and cell-type information can be more
readily extracted from imaging data than from electrophysiology.
Dye-based imaging has been conducted in combination with
optogenetic control in a number of studies, using Ca2+ dyes
such as fura-2 (Zhang et al., 2007) and Fluo-5F (Zhang and Oert-
ner, 2007), and voltage-sensitive dyes such as RH-155 (Airan
et al., 2007, 2009; Zhang et al., 2010). The development of new
and improved genetically encoded sensors for neural activity
(Lundby et al., 2008; Dreosti et al., 2009; Dreosti and Lagnado,
2011; Lundby et al., 2010; Tian et al., 2009) opens up a new
class of possibilities for capitalizing on cell-type-specific readout
information that would complement the cell-type-specific play-in
of information provided by optogenetics. Although channelrho-
dopsin action spectra overlap to some extent with the excitation
spectra of these fluorophores, one canminimize photoactivation
during imaging by minimizing irradiance used to excite the
fluorophores, and by using scanning microscopy (confocal or
two-photon based).
When using scanning lasermicroscopy, the rapid ChR kinetics
that initially posed challenges for two-photon activation (Rickga-
uer and Tank, 2009) are actually favorable since Ca2+ imaging
can be performed by two-photon excitation with minimal photo-
activation of ChRs. Indeed, Zhang and Oertner used two-photon
imaging of the Ca2+ dye Fluo-5F to record dendritic calcium
transients evoked with either ChR2 photostimulation or direct
current injections in individual neurons in the slice culture
preparation (Zhang and Oertner, 2007), while Guo et al. used
GCaMP2 in C.elegans neurons, using a low wide-field light
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et al., 2009) to avoid unwanted photostimulation by the
fluorescence excitation light. Finally, spectrotemporal properties
of the newer channelrhodopsins offer additional possibilities for
combinatorial and all-optical circuit interrogation; red-shifted
tools, such as the newly developed C1V1 (Yizhar et al., 2011a)
in which peak excitation is further shifted from both the Fura-2
and GCaMP spectra, are even more well suited for integration
with Ca2+ imaging.
fMRI
Integration of optogenetic control with blood oxygenation level-
dependent (BOLD) fMRI readout (ofMRI; Lee et al., 2010) led to
the observation that local cortical excitatory neurons could
trigger BOLD responses that captured complex dynamics of
previously measured sensory-triggered BOLD, providing a
causal (rather than the prior correlative) demonstration of suffi-
ciency of coordinated spikes in defined cell types for eliciting
the complex dynamics of BOLD signals. It remains to be seen
which circuit elements are necessary (rather than sufficient) for
distinct phases of BOLD responses in various experimental
settings, and this complexity may now be explored with ofMRI
(Lee et al., 2010; Leopold, 2010; Desai et al., 2011; Li et al.,
2011). Beyond the question of BOLD signal generation, the
most significant value of ofMRI will be as a research tool for
mapping global impact of defined cells, and perhaps identifying
disease-related circuit endophenotypes, in a manner not
feasible with microelectrodes, since specific local cells (or
specific distant cells defined by axonal wiring) can be directly
accessed in the setting of global BOLD mapping. Downstream
activation of other networks, regions, cells, and circuit elements
is then appropriately dictated by the output of the targeted
components.
Outlook
Advances in optogenetics have opened up new landscapes in
neuroscience and indeed have already been applied beyond
neuroscience to muscle, cardiac, and embryonic stem cells
(Arrenberg et al., 2010; Bruegmann et al., 2010; Stirman et al.,
2011; Weick et al., 2010; Stroh et al., 2011; Tønnesen et al.,
2011). Disease models have also been explored, including for
Parkinson’s disease, anxiety, retinal degeneration, respiration,
cocaine conditioning, and depression (Gradinaru et al., 2009;
Covington et al., 2010; Alilain et al., 2008; Kravitz et al., 2010;
Witten et al., 2010; Busskamp et al., 2010; Tye et al., 2011).
The temporal precision enabled by the use of light along with
the single-component microbial opsin strategy is crucial across
all fields for delivering a defined event in a defined cell population
at a specific time relative to environmental events. Moreover,
optogenetic tools may now be selected from a broad and ex-
panding palette (Figure 1) for specific electrical or biochemical
effector function, speed, action spectrum, and other properties.
Advances in tool functionality and targeting/readout enabling-
technologies have allowed the core goal of optogenetics in
neuroscience to be achieved: millisecond-scale optical control
of defined small-scale events occurring in specified cellular
populations while these populations remain embedded and
functioning within freely moving mammals or other intact and
complex biological systems.ACKNOWLEDGMENTS
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